Improved Methods of Sepsis Case Identification and the Effects of Treatment with Low Dose Steroids: A Dissertation by Zhao, Huifang
University of Massachusetts Medical School 
eScholarship@UMMS 
GSBS Dissertations and Theses Graduate School of Biomedical Sciences 
2011-01-22 
Improved Methods of Sepsis Case Identification and the Effects 
of Treatment with Low Dose Steroids: A Dissertation 
Huifang Zhao 
University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss 
 Part of the Bacterial Infections and Mycoses Commons, Diagnosis Commons, Endocrine System 
Commons, Health Information Technology Commons, Health Services Research Commons, Hormones, 
Hormone Substitutes, and Hormone Antagonists Commons, Pathological Conditions, Signs and 
Symptoms Commons, Pharmaceutical Preparations Commons, Polycyclic Compounds Commons, and 
the Therapeutics Commons 
Repository Citation 
Zhao H. (2011). Improved Methods of Sepsis Case Identification and the Effects of Treatment with Low 
Dose Steroids: A Dissertation. GSBS Dissertations and Theses. https://doi.org/10.13028/hq54-sj58. 
Retrieved from https://escholarship.umassmed.edu/gsbs_diss/529 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and 
Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
 IMPROVED METHODS OF SEPSIS CASE IDENTIFICATION AND THE EFFECTS 
OF TREATMENT WITH LOW DOSE STEROIDS 
 
A Dissertation Presented 
By 
Huifang Zhao 
 
Submitted to the Faculty of the  
University of Massachusetts Graduate School of Biomedical Sciences, Worcester  
in partial fulfillment of the requirements for the degree of 
 
DOCTOR OF PHILOSOPHY 
 
 
JANUARY 22ND, 2011 
CLINICAL AND POPULATION HEALTH RESEARCH 
 
 
 
ii 
IMPROVED METHODS OF SEPSIS CASE IDENTIFICATION AND THE EFFECTS 
OF TREATMENT WITH LOW DOSE STEROIDS 
 
A Dissertation Presented 
By 
Huifang Zhao 
 
The signature of the Dissertation Defense Committee signifies  
completion and approval as to style and content of the Dissertation 
 
 
Craig M. Lilly, M.D., Thesis Advisor 
 
 
Sybil Crawford, Ph.D., Member of Committee 
 
 
Stephen Heard, M.D., Member of Committee 
 
 
Gyorgy Frendl, M.D., Ph.D., Member of Committee 
 
The signature of the Chair of the Committee signifies that the written dissertation meets  
the requirements of the Dissertation Committee 
 
 
 
Robert Goldberg, Ph.D., Chair of Committee 
 
 
 
iii 
The signature of the Dean of the Graduate School of Biomedical Sciences signifies  
that the student has met all graduation requirements of the school.  
 
 
Anthony Carruthers, Ph.D. 
Dean of the Graduate School of Biomedical Sciences 
 
 
Clinical and Population Health Research 
January 22nd, 2011 
 
 
 
iv 
 
DEDICATION 
 
 
To my beloved husband, Hangsheng, 
who always supports me in my determination to find and to realize my potential 
 
 
 
 
v 
 
ACKNOWLEDGEMENTS 
 There are a number of people without whom this thesis would not have been 
possible. I would like to show my gratitude to my mentor, Dr. Craig Lilly, who shows 
great passionateness and enthusiasm even in the darkest days. I am indebted to my thesis 
committee chair, Dr. Robert Goldberg for his remarkable guidance on shaping this thesis 
framework, exceptional insights and sense of humor. I would also like to show my 
deepest gratitude to Dr. Sybil Crawford. I truly appreciate her invaluable guidance, 
wisdom, kindness, and constant support. I am also indebted to Dr. Stephen Heard for his 
exceptional guidance, his inspiration, and invaluable insights, which go beyond what I 
can cite here. Many thanks to Dr. Gyorgy Frendl, from whose clinical expertise and 
research capability I have benefited enormously. I would also like to thank Dr. Marie 
Mullen for her unwavering support and extraordinary contribution to this work.  
 Special thanks to Dr. Carole Upshur - I am tremendously appreciative of the 
support she gave me along the journey which we knew would be immensely challenging 
and painful. Many thanks to CPHR program faculty and my fellow students, who played 
such important roles in helping me continue the journey, as we mutually understand the 
challenges we faced. I am very grateful to Nancye Araneo for her extraordinary help on 
my scientific writing. 
 Loving thanks go to Karen Landry and Deena Burkhardt, my dearest warm-
hearted friends. Their readiness to help, emotional encouragement, willingness to wipe 
 
 
 
vi 
tears off my face, and delicious coffee and cookies have kept me from feeling lonely, 
especially at those times when it seemed impossible to continue.  
 It’s a pleasure to thank those who work in the eICU support center, including but 
not limited to: Linda Doherty, Greg Wongkam, Nick Hemeon, Sheryl Lopriore, Sheryl 
Dunlington, and Shawn Cody. I am also very grateful to the ones who have helped me 
along this journey - formally or informally; thank you for being there helping me.  
 Last but not least, a very special thank you to my husband, Hangsheng, for his 
practical and emotional support as I struggled with the competing demands from study, 
work, and personal development.  
 
 
 
vii 
ABSTRACT 
 Sepsis is the leading cause of death among critically ill patients and the 10 th most 
common cause of death overall in the United States. The mortality rates increase with 
severity of the disease, ranging from 15% for sepsis to 60% for septic shock. Patient with 
sepsis can present varied clinical symptoms depending on the personal predisposition, 
causal microorganism, organ system involved, and disease severity. To facilitate sepsis 
diagnosis, the first sepsis consensus definitions was published in 1991 and then updated 
in 2001. Early recognition of a sepsis patient followed with timely and appropriate 
treatment and management strategies have been shown to s ignificantly reduce sepsis-
related mortality, and allows care to be provided at lower costs. Despite the rapid 
progress in the knowledge of pathophysiological mechanisms of sepsis and its treatment 
in the last two decades, identifying patient with sepsis and therapeutic approaches to 
sepsis and its complications remains challenging to critical care clinicians. Hence, the 
objectives of this thesis were to 1) evaluate the test characteristics of the two sepsis 
consensus definitions and delineate the differences in patient profile among patients 
meeting or not meeting sepsis definitions; 2) determine the relationship between the 
changes in several physiological parameters before sepsis onset and sepsis, and to 
determine whether these parameters could be used to identify sepsis in critically ill 
adults; 3) evaluate the effect of corticosteroids therapy on patient mortality.  
 Data used in this thesis were prospectively collected from an electronic medical 
record system for all the adult patients admitted into the seven critical care units (ICUs) 
in a tertiary medical center. Besides analyzing data at the ICU stay level, we investigated 
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patient information in various time frames, including 24-hour, 12-hour, and 6-hour time 
windows. 
 In the first study of this thesis, the 1991 sepsis definition was found to have a high 
sensitivity of 94.6%, but a low specificity of 61.0%. The 2001 sepsis definition had a 
slightly increased sensitivity but a decreased specificity, which was 96.9% and 58.3%, 
respectively. The areas under the ROC curve for the two consensus definitions were 
similar, but less than optimal. The sensitivity and area under the ROC curve of both 
definitions were lower at the 24-hour time window level than those of the unit stay level, 
though the specificity increased slightly. At the time window level, the 1991 definitions 
performed slightly better than the 2001 definition. 
 In the second study, minimum systolic blood pressure performed the best, 
followed by maximum respiratory rate in discriminating sepsis patients from SIRS 
patients. Maximum heart rate and maximum respiratory rate can differentiate sepsis 
patients from non-SIRS patients fairly well. The area under ROC of the combination of 
five physiological parameters was 0.74 and 0.90 for comparing sepsis to non- infectious 
SIRS patients and comparing sepsis to non-SIRS patients, respectively. Parameters 
typically performed better in 24-hour windows compared to 6-hour or 12-hour windows. 
 In the third study, significantly increased hospital mortality and ICU mortality 
were observed in the group treated with low-dose corticosteroids than the control group 
based on the propensity score matched comparisons, and multivariate logistic regression 
analyses after adjustment for propensity score alone, covariates, or propensity score (in 
deciles) and covariates. 
 
 
 
ix 
 This thesis advances the existing knowledge by systemically evaluating the test 
characteristics for the 1991 and 2001 sepsis consensus definitions, delineating 
physiological signs and symptoms of deterioration in the preceding 24 hours prior to 
sepsis onset, assessing the prediction performances of single or combined physiological 
parameters, and examining the use of corticosteroids treatment and survival among septic 
shock patients. In addition, this thesis sets an innovative example on how to use data 
from electronic medical records as these surveillance systems are becoming increasingly 
popular. The results of these studies suggest that a more parsimonious set of definitional 
criteria for sepsis diagnosis are needed to improve sepsis case identification. In addition, 
continuously monitored physiological parameters could help to identify patients who 
show signs of deterioration prior to developing sepsis. Last but not least, caution should 
be used when considering a recommendation on the use of low dose corticosteroids in 
clinical practice guidelines for the management of sepsis.  
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Chapter I  Introduction 
 
 
1.1 Background and Significance 
Definition of sepsis 
 The systemic inflammatory response syndrome (SIRS) is a generalized 
physiological response to a wide variety of pro- inflammatory disease states, including 
infection, trauma, burns, and pancreatitis, which is characterized by pathological changes 
in body temperature, tachycardia, tachypnea, and abnormalities in total and differential 
white blood cell count.  Sepsis is defined as SIRS with an infectious etiology and can be 
further categorized as severe sepsis, when infection and the host response result in organ 
dysfunction (e.g., acute renal failure), or as septic shock, when sepsis is complicated by 
acute circulatory failure characterized by persistent arterial hypotension despite adequate 
volume resuscitation.1, 2 
 
Epidemiology of sepsis in US 
 Sepsis is the leading cause of death among critically ill patients in non-coronary 
intensive care units (ICUs) and the 10th most common overall cause of death in the 
United States.3 There is increasing evidence that the incidence of sepsis has been 
increasing over time in the American population, from 164,000 cases (83 per 100,000 
population) in 1979 to nearly 660,000 (240 per 100,000 population) in 2000.3, 4 Sepsis is 
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often lethal, and its mortality rates range from 15% for sepsis to 60% for septic shock in 
the early 2000s.5-7 Certain vulnerable sub-populations, such as persons 65 years or older, 
neonates and infants, immunocompromised individuals, and critically ill patients, are at 
increased risk for developing severe sepsis.8 In fact, the number of deaths attributable to 
severe sepsis and myocardial infarction are approximately the same. Caring for patients 
with sepsis costs as much as $50,000 per patient, resulting in an economic burden of 
nearly $17 billion annually in the US, on an annual basis.9  
 
Evolvement of sepsis definition 
 Prior to 1991, the physiological derangements characteristic of sepsis were 
referred to by a variety of terms that were often used interchangeably, including “sepsis”, 
“septicemia”, “septic syndrome”, “bacteremia”, “infection”, and “septic shock.” The lack 
of a consensus case definition complicated the evaluation of studies by clinicians and 
researchers.10, 11 In 1991, the American College of Chest Physicians and the Society of 
Critical Medicine convened a conference that published consensus definitions of sepsis, 
severe sepsis, and septic shock.  Sepsis was defined as the combination o f infection and a 
systemic inflammatory response. Severe sepsis was defined as sepsis complicated by 
organ dysfunction. Septic shock in adults was defined as “acute circulatory failure 
characterized by persistent arterial hypotension” (systolic arterial pressure < 90 mmHg, 
mean arterial blood pressure <60, or > 40 mmHg reduction from baseline in systolic 
blood pressure), despite adequate volume resuscitation, and unexplained by other causes.1 
A new syndrome termed SIRS was introduced to define when this systemic response was 
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present. Patients meeting any 2 of the following criteria were defined as having SIRS: 
body temperature ≥38°C or <36°C, heart rate >90/min, respiration >20/min or PaCO2 
<32 mmHg, and white blood cell count >12.0 x 109/L or <4.0 x 109/L.  The utility and 
biological implications of a systemic inflammatory response to infection were soon 
evident and the term SIRS evolved from an epidemiological construct to a term used by 
bedside clinicians.12-15  
  Experience with the 1991 case definitions led to concerns for its validity, 
including its characteristics of being overly sensitive but not specific.16, 17 An 
international conference was convened in 2001 to reappraise, enhance, and improve upon 
the 1991 definition. The expanded definition of sepsis still required that documented or 
suspected infection be present, but it expanded the SIRS criteria to a list of 7 general, 5 
inflammatory, 3 hemodynamic, 7 organ dysfunction, or 2 tissue perfusion criteria, some 
of which also had to be present.2 Although there is good reason to believe that the 
expanded definition would more efficiently identify sepsis in its early stages, the degree 
to which the expansion by the 2001 case definition has caused more non infected 
individuals to meet the definition is unknown. In addition, the impact of these alterations 
on the case definition and on the test characteristics has not been well studied to date.  
 
Importance of the early diagnosis of sepsis 
 Early recognition and treatment for sepsis with appropriate antimicrobial agents18, 
19 and management strategies20 has been shown to significantly reduce sepsis-related 
mortality. The identification of the responsible pathogen provides guidance on narrower 
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spectrum antimicrobial therapy and is thought to reduce the emergence of antibiotic-
resistance microorganisms.21 The effective and early treatment of serious infections 
prevents progression to organ dysfunction or even septic shock, and allows care to be 
provided at lower cost.19   
 
Difficulty in making the early diagnosis of sepsis 
 Identifying patients with early sepsis can be difficult since non- infectious 
conditions, such as trauma and pancreatitis, can also cause the definitional criteria for 
SIRS to be met.22 The mechanistic explanation for this overlap is that sepsis and non-
infectious inflammatory disorders share common pathways that lead to the activation of 
cytokines, such as tumor necrosis factor alpha, that can cause the signs and symptoms of 
systemic inflammatory response used in the case definitions. Determining whether an 
infection is present can also be problematic, especially early in the evolution of sepsis 
before hypotension and organ failure are present. Indeed, identifying pathogens in 
patients with sepsis has been problematic and bacterial identification rates reported as 
low as 30% are not uncommon.12 Bacterial growth also depends on the site of infection 
and could be altered by prior antimicrobial therapy.23 Even when pathogens are 
identified, the time required to isolate and report them often greatly exceeds the time 
window when sepsis is present and not yet complicated by hypotension or organ 
dysfunction.20 Knowing how to best identify patients with early sepsis is critical for 
achieving better outcomes for patients with sepsis.   
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Treatment of severe sepsis and septic shock 
 Severe sepsis and septic shock represent a more severe stage along the continuum 
of systemic inflammatory response to infection. Mediated with multiple inflammatory 
pathways and pro- inflammatory mediators including cytokines, patients at this stage 
usually fail to maintain homeostasis and develop abnormalities in circulation, which 
include increased vascular permeability, decreased intravascular volume, vasodilatation 
and depression of myocardial function, and imbalance among oxygen demand, oxygen 
extraction and oxygen delivery. Correspondingly, the therapeutic approach to severe 
sepsis and septic shock consists of initial volume and fluid resuscitation often combined 
with vasopressors and inotropic therapy, initiation of appropriate antimicrobial therapy, 
infection source identification and control, steroid therapy for patients who poorly 
respond to vasopressor therapy, and recombinant human activated protein C (rhAPC) for 
patients with high risk of death.24  Blood product usage is part of treatment as clinically 
indicated (red blood cell transfusions when the hemoglobin value is less than 7.0 g/dl; 
transfusion of platelets when the platelet count less than 5000/mm3 or the patient is at 
high risk of bleeding or requires an operative procedure). Supportive therapies 
(mechanical ventilation of sepsis- induced acute lung injury (ALI), or acute respiratory 
distress syndrome (ARDS); sedation, analgesia, and neuromuscular blockade, glucose 
control, renal replacement therapy, bicarbonate therapy, deep venous thrombosis 
prophylaxis therapy, and stress ulcer prophylaxis are also part of the approach to patients 
with sepsis.22, 25, 26  
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 Importantly, early goal-directed resuscitation during the first 6 hours after the 
recognition of hypoperfusion in septic patients, referred to as the “golden hours”, has 
demonstrated significant reductions in the 28-day mortality rate. Starting with fluid 
resuscitation subsequently combined with appropriate vasopressors, transfusion of red 
blood cells, and inotropic agents, patients are able to achieve the goals of central venous 
pressure (CVP) (8 – 12 mmHg), mean arterial pressure (MAP) (not less than 65 mmHg), 
urine output (greater than 0.5 mL·kg·hr), and central venous oxygen saturation (greater 
than 70%; or mixed venous oxygen saturation more than 65%). A few mechanisms 
contribute to the survival benefit of early goal directed therapy: reversal of circulatory 
abnormalities and tissue hypoxia, preventing cardiovascular collapse, and attenuating 
tissue hypoxia related endothelial cell activation and loss of barrier function, activation of 
the coagulation system, increased vascular permeability and reduced vascular tone.20 
 
Critical illness-related corticosteroid insufficiency (CIRCI) in septic shock 
 Activation of the hypothalamic-pituitary-adrenal (HPA) axis is an important 
adaptive process in critical illness for restoring and maintaining cellular and organ 
homeostasis. This activation leads to increased secretion of cortisol from the adrenal 
cortex, which is under the influence of adreno-corticotrophic hormone (ACTH) from the 
pituitary, and corticotropin-releasing hormone from the hypothalamus. During an acute 
illness, including severe infection, trauma, burns, and surgery, the product ion of cortisol 
can be increased by as much as six-fold, depending on the severity of the disease. 
Cortisol exerts protective physiologic effects through modulating metabolism (increasing 
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blood glucose concentration), cardiovascular function (maintaining microvascular 
perfusion, and increasing sensitivity of vascular muscle to endogenous or exogenous 
vasopressors agents), and the immune system (reducing transcription of proinflammatory 
factors, such as cytokine, chemokine, and eicosanoids, down-regulating immune cells’ 
number and their function).27, 28 
 Increasing evidence has shown that the adaptive HPA axis function is often 
impaired during critical illnesses including septic shock .29 The dysfunction could happen 
at any level of HPA axis function and contribute to either structural damage, or in most 
cases, reversible dysfunction of the HPA axis. The prevalence of CIRCI in severe sepsis 
and septic shock patients has been reported to be as high as 60% (by metyrapone testing) 
in ICUs.30, 31 The mechanism of HPA axis dysfunction is incompletely understood, but is 
thought to be related to insufficient cortisol production from adrenal or systemic 
inflammation-associated glucocorticoid resistance. As a result, the degree of HPA axis 
activation and severity of illness affects the function of metabolic, cardiovascular systems 
and immune response to severe infection in severe sepsis and septic shock.32, 33 
 
Steroid therapy in septic shock 
 Whether moderate-dose hydrocortisone improves mortality in septic shock 
patients is still controversial.32, 34, 35 Although there have been randomized controlled 
trials 34, 36-40 conducted to evaluate the survival benefits associated with the 
administration of  steroid therapy to septic shock patients, differences in study’s sample 
size, inclusion criteria, and characteristics of steroid administration (for example, starting 
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time, dosage, and treatment duration) have considerably limited our ability to derive  
meaningful comparisons across studies.  
   The contradictory results of the 2 better powered trials, namely the study by 
Annane et al. 34 and European multicenter study (CORTICUS) 36, have triggered debates 
with regard to the benefits of steroid use in septic shock patients. While the French multi-
center trial demonstrated significant 28-day mortality reduction among a subset of septic 
shock patients with abnormal HPA function who received corticosteroid therapy 
compared to those without corticosteroid therapy, the CORTICUS study did not illustrate 
improved survival among septic shock patients who received hydrocortisone regardless 
of HPA function. Several factors could possibly contribute to the observed differences 
between these two studies: 1) The patients’ characteristics were different. The patients 
enrolled in the French study were sicker than those in the CORTICUS study, with the 28-
day mortality in the comparison groups being 61%, 31.5%, respectively. In addition, all 
of the patients enrolled in the French study were mechanically ventilated before 
enrollment, while 88.2% (440 among 499 patients) received ventilatory support at the 
time of baseline enrollment in the CORTICUS study. 2) The treatments differed. The 
patients in the steroid therapy arm in the French study received both hydrocortisone and 
fludrocortisone for 7 days, whereas those in CORTICUS study received only 
hydrocortisone for a total of 11 days. 3) The enrollment time of the two studies also 
differed. Participants in the study by Annane et al. were enrolled within 8 hours after 
septic shock onset and within 72 hours for CORTICUS study. Recent meta-analyses of 
randomized trials reported heterogeneous effects of corticosteroids therapy on mortality, 
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which can vary across patient characteristics, underlying risk, treatment dose and 
duration.  
 
1.2 Specific aims 
 This dissertation analyzed the data from an adult intense care units (ICUs) 
electronic surveillance system to achieve the specific aims listed below: 
 
Aim 1: To assess the test characteristics (sensitivity and specificity) of the 1991 
and 2001 consensus case definitions of sepsis in a population of patients admitted 
to adult intensive care units using adjudicated sepsis cases as the reference 
standard; 
 
Aim 2: To determine the best method for identifying sepsis cases by defining the 
algorithms that optimize diagnostic performance for scoring elements of the 
sepsis case definition. These variables include heart rate, respiratory rate, blood 
pressure and body temperature that are continuously monitored and recorded into 
an electronic monitoring system; 
 
Aim 3: To examine the association between administration of steroid therapy and 
mortality at hospital and ICU discharge among septic shock patients; and to 
access its survival benefit, if it exists, being associated with certain patient 
characteristics  
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1.3 Study Significance 
 Sepsis is a treatable disease with an unfortunately high mortality rate. On the one 
hand, there is increasing evidence that early diagnosis followed by appropriate treatment 
with antimicrobials and other supportive management is beneficial. The difficulty of 
early diagnosis was recognized decades ago and it remains challenging today. Part of this 
is due to overlap in the clinical criteria that define SIRS and sepsis. Though the consensus 
definitions of sepsis are widely adopted in clinical practice, their test characterist ics, as 
well as the changes given by the expanded 2001 consensus definition, haven’t been well 
studied. Rigorous evaluations of sepsis consensus definitions are needed by calculating 
their test characteristics including sensitivity, specificity, and area under the receiver 
operating characteristic (ROC) curve. In addition, a systematic comparisons of the 1991 
and 2001 definitions are well justified to allow the consistent description and evaluat ion 
of patients with sepsis, streamline the interpretations of clinical trials and therapeutic 
interventions, and provide an evidence based approach for determining if the 2001 
conference achieved its aims of improving the utility of these definitions for case 
identification. 
 Despite a large number of investigations using these definitions, the test 
characteristics of the available diagnostic parameters have not been well validated, and 
none are widely clinically applied. These observations support the need to identify the 
best routinely available parameters for distinguishing patients with sepsis, particularly 
before the onset of organ dysfunction and hypotension. Moreover, current widely used 
electronic monitoring systems enables us to continuously monitor patient’s physiological 
 
 
 
11 
parameters, including heart rate, respiratory rate, blood pressure and body temperature, 
and values of these parameters were readily available for systematic analysis. It is likely 
that a model including these more completely collected parameters will have increased 
predictive power to detect septic patients from those with systemic inflammatory 
responses that are not due to infection. Furthermore, this model will also have 
implications for clinicians in terms of timely evaluation and diagnoses of septic patients.  
 While substantial progress has been made in our understanding of the effects of 
steroid therapy in septic shock patients, significant controversy remains surrounding the 
issue of whether administration of corticosteroids leads to survival benefits. The clinical 
significance of the third aim is to provide evidence about whether, in a clinical setting not 
constrained by clinical trial entry criteria, septic shock patients receiving steroid would 
have improved survival outcome. Moreover, it also enables us to investigate whether 
certain patient characteristics are associated with the effects of the low-dose 
corticosteroid treatment; whereas its survival benefit, if it exists, would differ across 
patient subgroups. 
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Chapter II Sepsis Definition Evaluation 
 
Aim 1 
 
An Evaluation of the Diagnostic Accuracy of the 1991 ACCP/SCCM and the 2001 
SCCM/ESICM/ACCP/ATS/SIS Sepsis Definition 
 
Abstract 
Background 
 The 1991 and 2001 sepsis case definitions are widely adopted in clinical practice. 
Limited research has been conducted comparing their test characteristics. In addition, the 
impact of these alterations for the 2001 case definitions and on the test characteristics has 
not yet been well studied. 
 
Objectives 
 To assess the test characteristics of 1991 consensus definition, and 2001 
consensus definition, respectively, compared to sepsis case adjudication by three senior 
intensive care clinicians.  
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Study Design 
 Patient demographic, physiological and laboratory data were collect from patients 
admitted into ICUs in a tertiary medical center. Sensitivity, specificity, and the area under 
the ROC curve for the two consensus definitions were calculated and compared by 
comparing the number of patients who met or did not meet consensus definitions versus 
the number of patients who were diagnosed with sepsis or not by adjudication. Logistic 
regressions were performed to identify significant independent factors associated with 
sepsis diagnosis. The analysis was conducted at the ICU unit stay level as well as at the 
24-hour time window level. Fever, high white blood cell count or immature white blood 
cell, low GCS score, edema, positive fluid, high cardiac index, low PaO2/FiO2 ratio, and 
high levels of creatinine and lactate were significantly related to sepsis of both definitions 
and adjudication. 
 
Results 
 Overall inter-rate reliability among the adjudicators was good (Kappa was 0.68). 
The 1991 sepsis definition had a high sensitivity of 94.6%, but a low specificity of 
61.0%. The 2001 sepsis definition had slightly increased sensitivity but decreased 
specificity, which were 96.9% and 58.3%, respectively. The area under the ROC curve 
was not statistically different (0.78 and 0.78, respectively). The sensitivity and area under 
the ROC curve of both definitions were lower at the 24-hour time window level than that 
of the unit stay level, though the specificity increased slightly. At the time window level, 
the 1991 definitions performed slightly better than the 2001 definition.  
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Conclusions 
 Both the 1991 and the 2001 sepsis definition have a high sensitivity but low 
specificity; the 2001 definition has slightly increased sensitivity and decreased 
specificity. The diagnostic performances of the two definitions range from modest to 
good compared to the adjudication results. A more parsimonious set of definitional 
criteria for sepsis diagnosis is likely to improve current sepsis case identification.
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2.1 Introduction 
 Sepsis has been recognized since antiquity 1 and is currently the leading cause of 
death among critically ill adults and the 10th most common cause of death in the United 
States. 2, 3  The incidence of sepsis increased from 164,000 cases (82.7 cases per 100,000 
population) identified in 1979 to nearly 660,000 (240.4 cases per 100,000 population) in 
2000. 4 Certain vulnerable sub-populations, such as people older than 65, neonates and 
infants, immuno-compromised individuals, and critically ill patients, are reported to be at 
a 1.8 to 65 fold increased risk of developing sepsis. 5-8  Despite advances in the care of 
septic patients, the mortality rates for sepsis in United States have remained high and 
range from 15% for uncomplicated sepsis to 60% for septic shock. 9, 10   
 Prior to 1991, the physiological derangements characteristics of sepsis were 
referred to by a variety of terms that were often used interchangeably, including “sepsis”, 
“septicemia”, “septic syndrome”, “bacteremia”, “infection”, and “septic shock.” The lack 
of a consensus case definition complicated the evaluation of studies and confused 
communication among clinicians and researchers. In 1991, the American College of 
Chest Physicians (ACCP) and the Society of Critical Care Medicine (SCCM) convened a 
conference in an attempt to provide a framework of standardized definitions of sepsis. 
The proposed consensus definitions of this conference included sepsis, severe sepsis, 
septic shock, and a newly introduced terminology of “systemic inflammatory response 
syndrome (SIRS)”. SIRS represents a systemic inflammatory response independent of the 
etiology, and was considered to be present when a patient meets any two of the following 
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criteria: body temperature ≥38°C or <36°C, heart rate >90/min, respiration >20/min or 
PaCO2 <32 mmHg, and white blood cell (WBC) count >12.0 x 109/L or <4.0 x 109/L, or 
>10% immature (band) forms. Sepsis was defined as a systemic inflammatory response 
caused by infection. Severe sepsis was defined as sepsis complicated by organ 
dysfunction, hypotension or hypoperfusion, and septic shock as a subset of severe sepsis 
with “sepsis induced hypotension” (systolic arterial pressure < 90 mmHg, or > 40 mmHg 
reduction from baseline in systolic blood pressure) with perfusion abnormalities, despite 
adequate volume resuscitation. 11 
 The utility and biological implications of a systemic inflammatory response to 
infection were soon evident and the term SIRS evolved from an epidemiological 
construct to a term used as a screening tool to enroll participants in clinical trials in the 
years that followed. 12 The wide adoption of these definitions allowed assessment of the 
test characteristics.  However, experience with the 1991 case definitions in clinical 
practice as well as in large sepsis clinical trials led to concerns for its validity. SIRS 
criteria alone appeared to be overly sensitive and yet not specific as most patients in 
Intensive Care Units (ICUs) and many patients in general wards were reported to meet 
SIRS criteria at some time point during their hospital stay, 9, 13-15 despite many of these 
patients were without clinical evidence of infection.  
 An international conference was convened in 2001 to reappraise, enhance, and 
improve upon the 1991 definition. The expanded definition of sepsis still requires that a 
documented or suspected infection be present, but it expanded the SIRS criteria to a list 
of 7 general, 5 inflammatory, 3 hemodynamic, 7 organ dysfunction, or 2 tissue perfusion 
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criteria, some of which had to also be present. 16 Although there is good reason to believe 
that the expanded definition more comprehensively captures systemic responses to 
infection and could more efficiently identify sepsis in its early stages, the impact of these 
alterations of the case definition on the test characteristics have not yet been well studied.  
 Though the consensus definitions of sepsis have been widely adopted in clinical 
practice, limited research has been conducted comparing their test characteristics. In 
addition, systematic comparison of the 1991 and 2001 definitions are well justified to 
allow the consistent description and evaluation of patients with sepsis, and allow more 
informative comparison of sepsis clinical trials and therapeutic interventions that used the 
alterative definitions. Therefore, the aim of this study is to assess the test characteristics 
(i.e. sensitivity, specificity, and the area under the ROC curve) of 1991 consensus 
definition, and 2001 consensus definition, respectively, compared to sepsis case 
adjudication by three senior intensive care clinicians.  
 
2.2 Methods  
Study Design 
   This is an observational study conducted in seven intensive care units (ICUs) of 
an academic medical center, including three medical, two surgical, one cardiac, and one 
mixed unit for trauma, burns, neurosurgical and strokes. The seven ICUs serve as the 
major source of intensive care in the greater Worcester, Massachusetts area. Patients 
admitted into the units originated from various sources, including the emergency 
department, general wards, operating rooms, and other hospitals or health care centers in 
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or adjacent to central Massachusetts. The medical center started employing an electronic 
medical record system in June 2006 and finished implementing the system in all seven 
ICUs before May, 2007. All consecutive ICU admissions to the ICUs from October 2007 
to December 2008 were included in this study as the study target population. This study 
was part of the “Identifying Patients with Sepsis” project conducted in our ICUs and data 
were collected from existing data base without patient identifiers under a waiver of 
informed consent from our Human Subjects Committee.  
 
Data collection 
 Patient demographic characteristics were acquired from the electronic medical 
records, including age, gender, race, marital status, height, weight, and admission source. 
Race was classified as white, black and other; marital status was categorized as married, 
single, or widowed. Admission source was classified as emergency department (ED), 
general wards, operating room, and other. Admission diagnosis was recorded at the time 
of ICU admission and classified by major body systems, which included cardiovascular, 
gastrointestinal, respiratory, genitourinary, neurology, and other system. Acute 
Physiology and Chronic Health Evaluation (APACHE) IV score, and one of its 
components, Acute Physiological Score (APS) (Cerner, Kansas City, MO) were 
calculated from data collected by the electronic medical record and used as the measures 
of patient acute severity. In addition, clinical outcomes such as hospital length of stay, 
ICU length of stay, hospital mortality, and unit mortality were also collected for the 
comparison between sepsis and non-sepsis patients.  
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 Physiological parameters included heart rate, respiratory rate, systolic blood 
pressure, mean blood pressure, temperature, urine output, edema, positive fluid balance, 
cardiac index, capillary refill or mottling, ileus, and Glasgow Coma Score. A patient’s 
physiological status was assessed and updated every 30 to 60 minutes during the initial 
24 to 48 hours of ICU stay and was updated every 2 to 4 hours when a patient was 
deemed stable or was ready for ICU discharge. Laboratory test results and their 
corresponding test time were also collected for WBC count, band, platelet, aPTT, INR, 
glucose, creatinine, total bilirubin, lactate, c reactive protein (CRP), PaO2, FiO2, 
PaO2/FiO2 ratio, PaCO2, SvO2, and microbiology tests (specimen type, site of 
acquisition, test time, sites with positive culture, organism type) from the electronic 
medical record system.  
 
Adjudication of sepsis cases 
 All the sepsis cases were adjudicated by three senior intensive care physicians by 
medical records review. The algorithm of case adjudication is illustrated in Figure 2.1. A 
patient with sepsis had to meet the SIRS criteria and have a confirmed diagnosis of 
infection. Patient was classified as having severe sepsis if the patient met organ 
dysfunction criteria.17 When the patient had hypotension despite adequate volume 
resuscitation, the case was diagnosed as having septic shock. The time when sepsis was 
present was also determined. For subjects that developed sepsis before or at the time of 
ICU admission, the disease onset time was taken as the time of ICU admission.  
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 A random sample of 1,000 patients, about 7.1% of all patients during the study 
period, was selected for sepsis adjudication. Each physician first completed the same 
training set which was consisted of 40 patients randomly selected from the 1,000 patients. 
A consensus meeting was then convened to resolve the differences and standardized the 
adjudication approach among physicians. A final sample of 960 patients were 
adjudicated, among whom 60 patients were reviewed by all three physicians. These 60 
patients were used to estimate the agreement between physicians based on the Kappa 
statistic. The Interpretation of Kappa value was: 0 as poor; 0 to 0.2 as slight; 0.2 to 0.4 as 
fair; 0.4 to 0.6 as moderate; 0.6 to 0.8 as substantial; and 0.8 to 1.0 as almost perfect 
agreement 18. 
 
Analysis Unit 
 The main analysis was conducted at the ICU unit stay level: a patient was 
classified as having sepsis if she/he was adjudicated as sepsis or met the sepsis definition 
any time during the ICU stay. Furthermore, analysis was performed at the 24-hour time 
window level because sepsis might not be present during the whole ICU stay. Within 
each of 24-hour time window, sepsis determined using the criteria of the 1991 or 2001 
definitions was compared to presence of sepsis by adjudication. In addition, sensitivity 
analysis was conducted assuming sepsis was present for 2 and 5 days after its diagnosis 
to check the robustness of the results. The reason is that sepsis usually requires a standard 
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course of antimicrobial treatment based on the infected site and organism type, and 
during the treatment course, patients were considered to continuously have sepsis.  
 
Statistical Analysis 
 Patient baseline demographic variables, admission diagnosis, and disease severity 
were summarized by calculating means for continuous variables and frequencies for 
categorical variables. The highest values or lowest values of each variable, as indicated 
by consensus definitions during the ICU stay or within each time window was used to 
determine whether a patient met specific criteria of consensus definitions. We then 
tabulated and compared the number of patients who met or did not meet consensus 
definitions versus the number of patients who were diagnosed with sepsis or not by 
adjudication. Using the adjudicated outcome as the reference standard, sensitivity, 
specificity, and the area under the ROC curve were calculated compared for the two 
consensus definitions. It is likely that many patients were diagnosed as having sepsis at 
the time of ICU admission, and these patients might be different, in patient 
characteristics, underlying diseases, acuity, infectious pathogen, from those who 
developed sepsis during their ICU stay. Therefore, a subgroup analysis was conducted for 
those patients with a diagnosis of sepsis at the time of ICU admission. Finally, logistic 
regressions were performed at the 24-hour window level to identify significant 
independent factors associated with sepsis diagnosis, where robust standard errors were 
used to account for the dependence between observations within the same patient 
(regression analyses using generalized estimating equations did not converge, which 
 
 
 
28 
might be due to the fact that 89% of adjudicated cases had a sepsis diagnosis at the time 
of ICU admission so that only one time window was available for these cases). 
 
2.3 Results 
Patient Characteristics 
 The final analytical sample consisted of 960 patients, among them, 353 (36.8%) 
were adjudicated as sepsis (n=83), severe sepsis (n=150), or septic shock (n=120). As 
illustrated in Table 2.1, no significant differences were present between sepsis patients 
and non-sepsis patients with regard to age, gender, race, marital status, and body mass 
index. However, sepsis patients had higher acuity, as measured by APS score (63.6 vs. 
45.3, p<0.01) and APACHE IV score (77.0 vs. 57.1).  About one quarter of sepsis 
patients were transferred from wards, compared to 12.7% of non-sepsis patients. Sepsis 
patients were less likely to be admitted from an operating room than non-sepsis patients 
(11.1% vs. 24.2%). A larger proportion of sepsis patients had an admission diagnosis of 
cardiovascular or respiratory disease. Without exception, sepsis patients had worse 
clinical outcomes for all measures, longer hospital (15.5 vs. 9.2) and ICU length of stay 
(7.8 vs. 3.6), and higher hospital (26.1% vs. 10.2%) and ICU mortality (17.9% vs. 6.9%).  
 As shown in Table 2.2, we compared three groups of sepsis patients determined 
by adjudication (353 patients), the 1991 sepsis definition (571 patients), and 2001 sepsis 
definition (595 patients), respectively. Despite the large differences in the number of 
sepsis patients identified using these 3 methods, the patient characteristics were very 
similar. No statistically significant different characteristics were found between 
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adjudicated sepsis cases and those determined by the 1991 definition, or between the 
cases determined by the two definitions. Nevertheless, adjudicated sepsis patients seemed 
to be sicker than those identified by the 2001 definition, as indicated in the mean APS 
score (63.6 vs. 59.5, p<0.05) and APACHE score (77.0 vs. 72.6, p<0.05). Furthermore, 
ICU length of stay was significantly longer among adjudicated sepsis cases than that of 
the sepsis patients determined by the 2001 definition (7.8 vs. 6.7, p<0.05).  
 
Sepsis Adjudication 
 Each of three senior physicians, who specialized in intensive care, adjudicated 
one third of ICU cases. There were 60 cases adjudicated by all three physicians, and the 
inter-rater reliability between physicians was evaluated using Kappa statistic. When 
patients were classified as sepsis or non-sepsis, the Kappa statistics for any two of the 
three physicians were 0.66, 0.73, and 0.64, respectively. The overall Kappa statistic was 
0.68. When patients were classified as non-sepsis, sepsis, severe sepsis, and septic shock, 
the Kappa statistics decreased. For pair-wise comparisons, the Kappa statistic ranged 
from 0.55 to 0.66, whereas the overall Kappa statistic was 0.61. 
 
Test Characteristics of the 1991 and 2001 Definitions 
 As shown in Table 2.3, compared to the adjudication results at the unit stay level, 
i.e., whether a patient ever had sepsis during the ICU stay, both definitions had a high 
sensitivity (94.6% and 96.9%, respectively) but a low specificity (61.0% and 58.3%%, 
respectively). The area under the ROC curve was not statistically different (0.78 and 
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0.78, respectively). The sensitivity of both definitions (77.7% and 81.1%%, respectively) 
was much lower at the time window level than that of the unit stay level, though the 
specificity increased slightly. The area under the ROC curve was also lower at the time 
window level, and the 1991 definitions performed slightly better than the 2001 definition 
(0.72 vs. 0.70, p<0.01). When it was assumed that sepsis diagnosis was present for at 
least 2 and 5 days, the sensitivity increased but the specificity decreased, and the area 
under the ROC curve was lower compared to those of the unit stay level and the time 
window level. In these cases, the 1991 definition’s area under the ROC curve was slightly 
larger than that of the 2001 definition. The majority of sepsis patients (89.0%) in this 
study had an admission diagnosis of sepsis. Subgroup analysis of these patients found 
similar test characteristics of the two sepsis definitions compared to those observed in the 
main analysis (Appendix Table 2.1).  
 
Significant Biophysical Parameters for the Prediction of Sepsis 
 The majority of the definition criteria were significantly associated with sepsis by 
definition or adjudication based on bivariate analyses (see details in Appendix Table 2.2). 
Table 2.4 presents the biophysical parameters that were significant predictors of sepsis 
based on regression analysis. The dependent variables of three regressions were 
adjudicated outcome, sepsis as defined by the 1991 definition, and sepsis as defined by 
the 2001 definition. There were ten biophysical parameters that appeared to be significant 
predictors in all regressions, including fever (temperature >38°C), white blood cell count 
>12.0 x 109/L or <4.0 x 109/L, band (immature white blood cell >10%), GCS (Glasgow 
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coma score <15), edema, positive fluid balance (>20 ml/kg in 24 hours), cardiac index  
>3.5 L/min/M, PaO2/FiO2 <300, creatinine >0.5 ml/dL, and lactate >1 mmol/L. 
Hypothermia, respiratory rate, PaCO2, and heart rate were significant in the regressions 
using the 1991 and 2001 definitions, but not in the regression based on the adjudication 
outcome. Abnormal SvO2 appeared in only two cases and perfectly predicted non-sepsis 
cases, which was also the case for Ileus (absent bowel sounds) in 88 adjudicated non-
sepsis cases. 
 
2.4 Discussion 
 Sepsis is a complex disease and the underlying pathobiological mechanisms have 
not been completely delineated. Accurate and reliable definitions of sepsis are 
fundamental for early disease identification, which thus allows timely therapeutic 
intervention, and improved interpretation and application of knowledge from clinical 
studies. This study was conducted to examine the test characteristics of the 1991 and the 
2001 sepsis consensus definitions. We found that, compared to adjudicated sepsis, both 
the 1991 and 2001 definitions had relatively high sensitivity and low specificity. The 
criteria used for the two definitions include signs and symptoms that a patient could 
present with during the course of infection- induced systemic inflammatory response. 
However, they are not specific to sepsis, and many other conditions could also manifest 
these signs and symptoms. For example, tachycardia and tachypnea may be present in 
heart failure, anemia, respiratory failure, and hypovolemia. Increased white blood cell 
count is not rare in conditions like trauma, pancreatitis, hemorrhage, myocardial 
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infarction, and pulmonary edema. Furthermore, both the 1991 and 2001 sepsis definitions 
had suboptimal differentiation performance, as measured by AUCs, which could be due 
to the overlap of these signs and syndromes with other diseases.  
 Expanding the sepsis definition by including a detailed list of possible 
manifestations of sepsis, the 2001 consensus definitions more inclusively reflect the 
spectrum of clinical responses to infection. Compared to the 1991 definition, the 2001 
sepsis definition had a slightly increased sensitivity and decreased specificity. This was 
expected since the added criteria in 2001 sepsis definition, like the other criteria in the 
1991 sepsis definition, are not specific for sepsis; whereas, other conditions could also 
present with these signs and symptoms. When looking across entire ICU stay, the area 
under the ROC curve of the 2001 sepsis definition was not significantly different from 
that of the 1991 sepsis definition which suggests that using the 2001 definition does not 
improve the discriminatory power compared to the 1991 definition. In deed, at a 24-hour 
time window level, we found decreased diagnostic performance of the 2001 definitions 
than that of the 1991 definition. Moreover, the extended list of possible signs of systemic 
responses in the 2001 definition is complicated and less parsimonious.  
 When taking into account the time of sepsis diagnosis by evaluating more 
clinically relevant time windows, the differences between adjudicated sepsis and the two 
definitions were larger, as reflected by a decreased sensitivity and area under the ROC 
curve. Since both of the current definitions do not specify a time frame, it is not clear 
within what time frame a patient meeting the defined criteria can be diagnosed with 
sepsis. This makes it difficult to design a retrospective study where a time window has to 
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be defined in an arbitrary way. For the purpose of this study, it was defined as a 24-hour 
window since routine laboratory testing is reviewed on a daily basis. In addition, as all 
the adjudication was conducted retrospectively by reviewing patient progress notes, it 
was challenging to precisely identify the exact time when a patient developed sepsis. On 
the other hand, as every input into the electronic medical record system has a 
corresponding recording time, our analytic algorithm determined the onset time of sepsis 
as the time when a patient had both a diagnosis of infection and met any two of the SIRS 
criteria. When the diagnoses using the 1991 and 2001 definitions based on electronic data 
were compared to the manually adjudicated diagnoses at the time window level rather 
than the unit stay level, the area under the ROC curve declined, especially that of the 
2001 definition. Since the test characteristics varied depending on the time frame within 
which diagnostic criteria are evaluated, it may be useful for clinicians if a guideline is 
provided in the sepsis definition regarding the time frame within which the defined 
criteria should be met in order to diagnose a patient as having sepsis.  
 From our regression analyses, we identified the predictors of sepsis diagnosis. 
Given the complexity of using the extended list of diagnostic criteria as defined in the 
2001 definition, one possible solution is to shorten the list based on a more parsimonious 
set of criteria as identified by regressions analyses. We found that significant predictors 
of the 2001 definition, including fever, white blood cell count, the presence of early 
myeloid forms (bands), GCS, edema, positive fluid balance, cardiac index, PaO2/FiO2, 
creatinine, and lactate, whereas in the 1991 definition, 2 of the 4 SIRS criteria 
(respiratory rate and heart rate) were not among the set of predictors that were significant 
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in all regressions. As these were significant predictors of sepsis, it is likely that using 
them will improve specificity for sepsis diagnosis with a minimal decrease in sensitivity. 
A further approach would be to create a weighting system that assigns different weights 
(e.g., based on the magnitude and precision of estimated coefficients) for various criteria 
because some criteria may contribute more than others as indicated by their odds ratios. 
For instance, having white blood cell with >10% in early myeloid forms (band) was 
associated with 6-fold increased risk of developing sepsis, and patients with abnormal 
lactate were nearly 7 times more likely to have sepsis than those with a normal lactate 
level. Additional research using larger dataset is warranted to further validate the new set 
of criteria and generate a weighting system empirically.  
 Strengths of our study include careful and rigorous data collection in an electronic 
medical record system; the independent adjudication of sepsis based on medical records 
by the three adjudicators; clearly defined time windows that reflect bedside clinical 
practice and a thorough exploration of our data. This study has several important 
limitations. First, only patients admitted to an adult ICU were included in this study. As a 
result, the findings might not be generalizable to other settings such as emergency rooms 
or general wards or ICUs caring for less severely ill patients. Second, the agreement 
among adjudicators was substantial rather than perfect despite adjudicating practice cases 
and the consensus meetings before the final adjudication. Lastly, there were 960 patients 
included in the study. A larger sample size would be expected to generate more robust 
results.  
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2.5 Conclusions 
 Despite extensive efforts, sepsis diagnosis remains difficult as some other 
diseases states have similar clinical presentations and many share the same 
pathophysiological processes. Our findings suggest that both the 1991 and the 2001 
sepsis definition have a high sensitivity but low specificity. By expanding the SIRS 
criteria, the 2001 definition has slightly increased sensitivity and decreased specificity. 
The diagnostic performances of the two definitions range from modest to good compared 
to the adjudication results. A more parsimonious set of definitional criteria for sepsis 
diagnosis, identified and validated in future studies, is likely to improve the efficiency 
and reliability of current criteria for sepsis case identification. 
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Table 2.1   Patient Characteristics 
Characteristics Sepsis Patients 
(n=353) 
Non-Sepsis Patients 
(n=607) 
P Value 
Age, mean ± SD 64.82±16.62 63.28±17.00 0.17 
Female Gender, n (%) 158(44.76) 261(43.00) 0.60 
Race n (%)    
    White  302(85.55) 541(89.13) 0.10 
    Black 11(3.12) 15(2.47) 0.55 
    Other 40(11.33) 51(8.40) 0.14 
Married Status n (%) 158(44.76) 305(50.25) 0.10 
BMI, mean ± SD 28.01±7.76 28.41±7.68 0.44 
APS Score, mean ± SD 63.61±26.55 45.31±23.66 <0.01 
APACHE Score, mean ± SD 76.95±28.24 57.13±25.70 <0.01 
Admission Source, n (%)    
    Emergency Room 199(56.37) 356(58.65) 0.49 
    Ward  88(24.93) 77(12.69) <0.01 
    Operation Room 39(11.05) 147(24.22) <0.01 
    Other Hospital 27(7.65) 24(3.95) 0.01 
Operative Diagnosis, n (%) 40(11.33) 141(23.23) <0.01 
Admission Diagnosis, n (%)    
    Cardiovascular  98(27.76) 247(40.69) <0.01 
    Gastrointestinal 56(15.86) 81(13.34) 0.28 
    Respiratory  100(28.33) 57(9.39) <0.01 
    Genitourinary  12(3.40) 10(1.65) 0.08 
    Neurology 51(14.45) 115(18.95) 0.08 
    Other 36(10.20) 97(15.98) 0.01 
Clin ical Outcomes    
Hospital Length of Stay, mean ± SD 15.46±15.38 9.16±8.73 <0.01 
ICU Length of Stay, mean ± SD 7.76±8.51 3.64±3.94 <0.01 
Hospital Mortality 92(26.06) 62(10.21) <0.01 
Unit Mortality 63(17.85) 42(6.92) <0.01 
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Table 2.2   Characteristics of Sepsis Patients Determined Using Various Methods 
Characteristics Adjudicated 
Sepsis 
1991 Definition 2001 
Definition 
No. of Sepsis Cases (% ) 353 (36.77) 571 (59.48) 595 (61.98) 
Age, mean ± SD 64.82±16.62 64.06±17.20 64.25±17.15 
Female Gender, n (% ) 158(44.76) 263(46.06) 274(46.05) 
Race n (% )       
    White 302(85.55) 497(87.04) 518(87.06) 
    Black 11(3.12) 19(3.33) 19(3.19) 
    Other 40(11.33) 55(9.63) 58(9.75) 
Married Status n (% ) 158(44.76) 245(42.91) 259(43.53) 
BMI, mean ± S D 28.00±7.77 28.08±7.68 28.14±7.73 
APS Score, mean ± SD 63.61±26.55 60.22±26.78 59.48±26.72*  
APACHE Score, mean ± SD 76.95±28.24 73.25±28.40 72.57±28.31*  
Admission Source, n (% )       
    Emergency Room 199(56.37) 322(56.39) 341(57.31) 
    Ward 88(24.93) 134(23.47) 134(22.52) 
    Operation Room 39(11.05) 76(13.31) 80(13.45) 
    Other Hospital  27(7.65) 39(6.83) 40(6.72) 
Operative Diagnosis, n (% ) 40(11.33) 77(13.49) 80(13.45) 
Admission Diagnosis, n (% )       
    Cardiovascular  98(27.76) 159(27.85) 165(27.73) 
    Gastrointestinal 56(15.86) 86(15.06) 89(14.96) 
    Res piratory 100(28.33) 135(23.64) 140(23.53) 
    Genitourinary 12(3.40) 15(2.63) 15(2.52) 
    Neurology 51(14.45) 102(17.86) 112(18.82) 
    Other 36(10.20) 74(12.96) 74(12.44) 
Clinical Outcomes       
Hos pital  Length of Stay, mean ± SD 15.46±15.38 14.11±13.81 13.93±13.66 
ICU Length of Stay, mean ± SD 7.76±8.51 6.80±7.54 6.70±7.43*  
Hos pital  Mortality 92(26.06) 127(22.24) 128(21.51) 
Unit Mortality 63(17.85) 88(15.41) 88(14.79) 
* Comparison between adjudicated sepsis and those defined by the 2001 definition, p<0.05; ** p<0.01. All the comparisons 
between adjudicated sepsis and those defined by the 1991 definition were not statistically significant at the 5% level, as well 
as those between pat ients by two definitions. 
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Table 2.3   Test Characteristics of 1991 and 2001 Sepsis Definition╪ 
Characteristics 
1991 Definition 2001 Definition 
Sensitivity Specificity 
Area Under 
ROC 
Sensitivity Specificity 
Area Under 
ROC 
Unit Stay Level 94.6% 61.0% 0.778 96.9% 58.3% 0.776 
Time W indow Level 77.7% 66.0% 0.719 81.1% 58.8% 0.699** 
Time W indow Level: assume sepsis diagnosis valid for 2 
days 
87.2% 43.7% 0.655 90.1% 38.0% 0.640** 
Time W indow Level: assume sepsis diagnosis valid for 5 
days 
90.8% 38.9% 0.648 93.2% 35.8% 0.645* 
╪Adjudication outcome: 353 sepsis cases (37%), 607 of non-sepsis cases.      
* Comparing area under ROC curve between two definitions: p<0.05; ** p<0.01.       
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Table 2.4   Predictive Capability of Diagnostic Criteria in Sepsis Diagnosis  
(Regression Analysis)┼ 
Biophysical Parameters  
Adjudicated Outcome  
(Odds Ratio, 95% CI) 
1991 Definit ion  
(Odds Ratio, 95% CI) 
2001 Definit ion  
(Odds Ratio, 95% 
CI) 
Fever 1.56 (1.19, 2.05) 1.91 (1.70, 2.15) 1.63 (1.44, 1.85) 
Hypothermia  0.80 (0.51, 1.26) 1.40 (1.15, 1.71) 0.82 (0.69, 0.98) 
Respiratory Rate  1.04 (0.72, 1.50) 3.26 (2.82, 3.77) 1.22 (1.09, 1.37) 
PaCO2 1.02 (0.72, 1.44) 0.75 (0.62, 0.90) 0.64 (0.54, 0.75) 
WBC 1.50 (1.16, 1.95) 2.04 (1.86, 2.25) 1.30 (1.19, 1.42) 
Band 6.08 (4.50, 8.21) 3.76 (2.96, 4.77) 2.67 (2.14, 3.35) 
Heart Rate 1.01 (0.75, 1.35) 3.25 (2.92, 3.62) 1.27 (1.16, 1.39) 
GCS 1.40 (1.07, 1.85) 1.48 (1.34, 1.64) 1.58 (1.44, 1.73) 
Edema 0.44 (0.34, 0.57) - 1.29 (1.17, 1.41) 
Flu id 2.27 (1.11, 4.64) - 2.15 (1.83, 2.52) 
Glucose 2.12 (1.64, 2.74) - 1.00 (0.91, 1.09) 
CRP 2.59 (0.74, 9.10) - 1.09 (0.48, 2.48) 
Systolic Blood Pressure 1.25 (0.93, 1.69) - 1.14 (1.03, 1.27) 
Mean Blood Pressure 0.86 (0.62, 1.20) 1.19 (1.07, 1.32) 1.07 (0.97, 1.19) 
Card iac Index 0.22 (0.08, 0.61) - 0.22 (0.15, 0.32) 
PaCO2 & FiO2 1.55 (1.15, 2.09) 1.38 (1.24, 1.54) 1.30 (1.18, 1.45) 
Urine Output 0.98 (0.72, 1.34) 0.80 (0.71, 0.90) 0.78 (0.70, 0.87) 
Creat inine  1.43 (1.10, 1.86) 1.19 (1.08, 1.31) 1.19 (1.09, 1.30) 
PTINR 1.27 (0.86, 1.87) - 0.97 (0.82, 1.15) 
aPPT 0.68 (0.43, 1.07) - 1.10 (0.93, 1.30) 
Ileus╪ - - 1.01 (0.62, 1.65) 
Platelet  0.74 (0.53, 1.05) 1.10 (0.95, 1.28) 1.13 (0.98, 1.31) 
Total Bilirubin  2.31 (1.25, 4.27) 1.27 (0.91, 1.79) 1.30 (0.94, 1.80) 
Vasopressor 1.28 (0.89, 1.83) 0.73 (0.61, 0.88) - 
Lactate 6.68 (4.94, 9.05) - 1.74 (1.45, 2.09) 
Capillary  0.71 (0.52, 0.98) - 1.01 (0.91, 1.13) 
┼ Abnormal SvO2 predicted non-sepsis perfectly in 2 cases and thus was excluded from the regressions.  
╪ Presence of ileus predicted non-sepsis perfectly in 88 adjudicated cases.  
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Appendix Table 2.1   Test Characteristics of 1991 and 2001 Sepsis Definition among Patients with a Diagnosis of Sepsis at 
Admission╪ 
Characteristics 
1991 Definition 2001 Definition 
Sensitivity Specificity Area Under 
ROC 
Sensitivity Specificity Area Under 
ROC 
Unit Stay Level 94.9% 60.2% 0.775 97.5% 57.7% 0.776 
Time W indow Level 83.8% 66.7% 0.752 87.9% 59.5% 0.737** 
Time W indow Level: assume sepsis diagnosis valid for 2 
days 
89.1% 44.0% 0.665 92.4% 38.5% 0.655** 
Time W indow Level: assume sepsis diagnosis valid for 5 
days 
92.0% 39.3% 0.656 94.8% 36.8% 0.658 
╪Adjudication outcome: 314 sepsis cases (35%), 575 of non-sepsis cases.      
* Comparing area under ROC curve between two definitions: p<0.05; ** p<0.01.       
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Appendix Table 2.2   Predictive Capability of Diagnostic Criteria in Sepsis Diagnosis 
(Bivariate Analysis) ┼ 
Biophysical Parameters  
Adjudicated Outcome  
(Odds Ratio, 95% CI) 
1991 Definit ion  
(Odds Ratio, 95% CI) 
2001 Definit ion  
(Odds Ratio, 95% CI) 
Fever (>38°C) 2.21 (1.79, 2.73) 2.92 (2.65, 3.22) - 
Fever (>38.3°C) 2.45 (1.95, 3.07) - 2.38 (2.13, 2.67) 
Hypothermia  2.13 (1.57, 2.89) 1.23 (1.05, 1.45) 0.96 (0.82, 1.12) 
Respiratory Rate  1.70 (1.24, 2.33) 4.31 (3.74, 4.97) 1.67 (1.50, 1.86) 
PaCO2 4.17 (3.28, 5.29) 1.65 (1.43, 1.90) 1.30 (1.13, 1.50) 
WBC 3.33 (2.68, 4.14) 2.68 (2.47, 2.92) 1.73 (1.60, 1.87) 
Band 17.44 (13.87, 21.93) 5.14 (4.21, 6.28) 4.07 (3.32, 4.98) 
Heart Rate 1.82 (1.42, 2.33) 4.23 (3.81, 4.70) 1.69 (1.55, 1.84) 
GCS 1.54 (1.23, 1.93) 2.06 (1.88, 2.25) 2.04 (1.87, 2.21) 
Edema 0.58 (0.48, 0.71) - 1.66 (1.53, 1.80) 
Flu id 5.55 (2.79, 11.06) - 2.96 (2.54, 3.45) 
Glucose 4.01 (3.22, 4.99) - 1.32 (1.22, 1.44) 
CRP 4.37 (1.74, 11.00) - 1.34 (0.69, 2.61) 
Systolic Blood Pressure 2.72 (2.22, 3.33) - 1.45 (1.33, 1.58) 
Mean Blood Pressure 1.76 (1.36, 2.27) 1.42 (1.30, 1.56) 1.36 (1.25, 1.49) 
SvO2┼ 0.00 (0.00, 48.34) - 0.00 (0.00, 2.58) 
Card iac Index 0.46 (0.16, 1.38) - 0.36 (0.25, 0.52) 
PaCO2 & FiO2 3.56 (2.89, 4.39) 2.15 (1.98, 2.34) 1.91 (1.76, 2.08) 
Urine Output 1.38 (1.09, 1.74) 0.75 (0.68, 0.83) 0.76 (0.69, 0.84) 
Creat inine  2.84 (2.30, 3.50) 1.59 (1.47, 1.73) 1.56 (1.44, 1.69) 
PTINR 3.05 (2.34, 3.97) - 1.31 (1.13, 1.52) 
aPPT 1.36 (0.95, 1.95) - 1.15 (0.98, 1.34) 
Ileus╪ 0.00 (0.00, 1.09) - 1.12 (0.74, 1.70) 
Platelet  1.90 (1.47, 2.47) 1.36 (1.20, 1.54) 1.41 (1.25, 1.59) 
Total Bilirubin  4.13 (2.73, 6.27) 1.80 (1.36, 2.38) 1.96 (1.48, 2.60) 
Vasopressor 5.53 (4.38, 6.99) 1.35 (1.16, 1.57) - 
Lactate 20.61 (16.59, 25.60) - 2.78 (2.38, 3.24) 
Capillary  1.12 (0.87, 1.43) - 1.35 (1.22, 1.48) 
┼ Abnormal SvO2 predicted non-sepsis perfectly in 2 cases.  
╪ Presence of ileus predicted non-sepsis perfectly in 88 adjudicated cases.  
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Figure 2.1 Sepsis Adjudication Flow Chart 
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Chapter III Early Prediction of Sepsis 
 
Aim 2 
 
Early Prediction of Sepsis in Critically Ill Patients -- Use of continuously monitored 
physiological parameters 
 
Abstract 
Background 
 Early recognition and treatment for sepsis remain challenging in clinical practice. 
The physiological criteria for SIRS and sepsis have been widely adopted by clinicians 
since their introduction, and are widely available in ICUs. However, it is currently 
unknown how to best utilize these sources of information for early recognition of sepsis 
cases. 
 
Objectives 
 To determine changes in several physiological parameters before the onset of 
sepsis and their relationship with sepsis onset, and to determine whether these parameters 
could be used to identify sepsis in critically ill adults 
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Study Design 
 Patient physiological data were collected from an electronic medical record 
system implemented in all the ICUs in a tertiary medical center. The patient population 
was randomly divided into a “derivation set” and a “validation set”. The physiological 
parameters within 24 hours, 12 hours, or 6 hours before sepsis onset were compared 
among sepsis, non- infectious SIRS and non-SIRS groups. The predictive performances 
were assessed for various measurements of each parameter, shock index, and the 
measurement of “trending” (the relationship of time and the changes in physiological 
parameters). The best (maximum value of area under the ROC curve) measurement of 
each physiological parameter was selected into regression models for predicting sepsis 
onset. 
 
Results 
 Parameters typically performed better in 24-hour windows compared to 6-hour or 
12-hour windows. Minimum systolic blood pressure performed the best, followed by 
maximum respiratory rate in discriminating sepsis patients from SIRS patients. 
Maximum heart rate and maximum respiratory rate can differentiate sepsis patients from 
non-SIRS patients fairly well. The area under ROC of the combination of five parameters 
reached 0.76 for comparing sepsis to SIRS in the training set and 0.74 in the validation 
set.  When comparing sepsis to non-SIRS, the area under the curve reached 0.94 in the 
training set and 0.90 in the validation set. Compared to the combinations, the 
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combination of the parameters’ trending and the shock index did poorly in differentiating 
sepsis from either SIRS or non-SIRS patients. 
 
Conclusions 
 Continuously monitored physiological parameters could help to identify patients 
who show signs of deterioration in the preceding 24 hours prior to developing sepsis.  
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3.1 Introduction 
 Sepsis is defined as a systemic inflammatory response syndrome (SIRS) with an 
infectious etiology that can progress into severe sepsis, when infection and the host 
response result in organ dysfunction, or septic shock, when sepsis is complicated by acute 
circulatory failure characterized by persistent arterial hypotension despite adequate 
volume resuscitation1, 2. Sepsis is the leading cause of death among critically ill patients 
and the 10th most common cause of death overall in the United States 3.  
 Early recognition and treatment for sepsis with appropriate antimicrobial agents 4, 
5 and management strategies 6 have been shown to significantly reduce sepsis-related 
mortality. However, accurately diagnosing of sepsis before patients deteriorate and 
develop organ dysfunction is an important goal that is often difficult to achieve in 
practice. The clinical symptoms of systemic inflammation are neither specific nor 
uniform since non- infectious conditions, such as trauma, thermal injury, seizures, 
toxidromes, and pancreatitis, can also cause the SIRS criteria to be present 7. Determining 
whether an infection is present can also be problematic because the bacterial 
identification rates for patients with sepsis has been reported as low as 30%8. In addition, 
bacterial growth also depends on the site of the infection, the ability to collect and 
process appropriate specimens, and previous antimicrobial treatment. The time required 
to isolate and report them can exceed the time window when sepsis is present without 
hypotension or organ dysfunction 6. Multiple biomarkers, including procalcitonin, c-
reactive protein (CRP), and interleukin- (IL) 6, have been proposed to facilitate a 
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physician’s ability to identify patients with sepsis; however, there is currently no 
universally accepted single biomarker or biomarker combinations for sepsis 9. Of the 
many candidate biomarkers investigated, plasma procalcitonin concentration has been 
investigated most comprehensively. Nevertheless, robust systematic reviews revealed 
procalcitonin had sub-optimal performance of discriminating sepsis from SIRS 10, 11. 
 The physiological criteria for SIRS and sepsis have been widely adopted by 
clinicians since their introduction. In addition, these criteria and hemodynamic 
parameters, which primarily focus on blood pressure, have been advocated as practice 
parameters for the hemodynamic management of septic patients 6, 12, 13. With the 
proliferation of constant surveillance monitoring of patients by means of the electronic 
medical record systems in intensive care units, the usefulness of the commonly, 
continuously available physiological parameters and their role in early recognition of 
sepsis cases are particularly appealing.  
 However, it is currently unknown how to best utilize these sources of information 
to identify patients with sepsis. One possible strategy would be to monitor changes in 
vital signs over time and measure their association with systemic inflammation response 
to infection. By analyzing the changing patterns of patients’ physiologic parameters, this 
strategy could have the potential of identifying pre-symptomatic patients with an 
increased risk for developing sepsis, facilitating physicians to initiate early and 
appropriate therapeutic intervention. In fact, a study of the perceptions and practices of 
critical care clinicians and nurses with regard to continuously monitor ing common 
physiological parameters reported that the majority of intensivists and critical care nurses 
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considered it important to continuously monitor hemodynamic parameters and routinely 
used these parameters for identifying signs of deterioration in patients with sepsis 14.  
Moreover, studies of critically ill infants have demonstrated that continuous heart rate 
characteristics monitoring aids the early diagnosis of neonatal sepsis 15-18. 
 Prior studies have attempted to use discrete physiological parameters, values that 
were recorded at the time of ICU admission, or the most abnormal value within the first 
24 hours of the ICU stay, to identify patient with sepsis 19-21. However, few studies have 
assessed the clinical usefulness of continuously monitored physiological parameters for 
adult patients with sepsis. Therefore, we conducted this study to determine changes in 
several physiological parameters before the onset of sepsis and their relationship with 
sepsis onset, and to determine whether these parameters could be used to identify sepsis 
in critically ill adults. The aims of our study were accomplished using the following 
stepwise approach. First, we evaluated the characteristics of each physiological parameter 
by measuring changes in these parameters during a time window of 24 hours, 12 hours, 
or 6 hours before sepsis diagnosis. Then, we compared the predictive performance of 
various measures of each parameter to identify candidate measures of these parameters. 
Third, various combinations of these physiological parameters’ candidate measures were 
constructed and their diagnostic accuracy for predicting sepsis onset was evaluated within 
the following 6, 12, or 24 hours, respectively. The specific physiological parameters 
chosen for this study included body temperature, heart rate, respiratory rate and blood 
pressure. They were termed “physiomakers”, as opposed to “biomarkers” which 
generally denote laboratory measurements. They were selected based on the definition 
 
 
 
52 
criteria 1, 2 and the recommendations from the guidelines of practice parameters for 
hemodynamic support 12, 13.  They are also widely and readily available to critical care 
providers, are among the “triggers” of suspension, and are frequently referred to when 
making a diagnosis of sepsis.  
 
3.2 Methods  
Study Design 
   This is an observational study conducted in seven intensive care units (ICUs), 
which includes three medical, two surgical, one cardiac, and one mixed unit for trauma, 
burn, neurosurgical and stroke, in a single academic tertiary care medical center. The 
seven ICUs serve as the primary sources of intensive care in the greater Worcester, 
Massachusetts area. Patients admitted into the units originate from various sources, 
including the emergency department, general wards, operating rooms, and other hospitals 
or health care centers in or adjacent to central Massachusetts. The medical center began 
employing an electronic medical record system in June, 2006 and finished implementing 
the system in all seven ICUs by May, 2007. All consecutive ICU admissions to the ICUs 
from October, 2007 to December, 2009 were included in this study. Since this study was 
part of the “Identifying Patients with Sepsis” project conducted in our ICUs, and data 
were collected from existing databases without patient identifiers, our hospital 
Institutional Review Board approved the study and waived the requirement of informed 
consent.  
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Patient Population 
 All consecutive adult patients admitted to any of the seven ICUs from October 
2007 to December 2008 were enrolled in this study. The patients were screened and 
categorized into three groups: 
Group 1: Sepsis group. Patients who had a recorded diagnosis of sepsis, severe sepsis, or 
septic shock in their electronic medical records during an ICU stay. To distinguish the 
different stages of sepsis, we defined sepsis as a less severe stage without organ 
dysfunction or septic shock. Severe sepsis was defined as sepsis complicated by organ 
dysfunction without fluid refractory hypotension. Septic shock was considered present 
when sepsis was complicated by circulatory failure despite fluid resuscitation 1, 2. Patients 
with an admission diagnosis of sepsis were excluded from this analysis since no data, 
including the physiological parameters prior to ICU admission, were available in the 
electronic medical record system. 
Group: 2 SIRS only group. Patients in this group met SIRS criteria but were never 
diagnosed with sepsis during their ICU stay. SIRS was defined as having two or more of 
the following conditions present: (1) temperature greater than 38 °C or less than 36 °C; 
(2) heart rate greater than 90 beats per minute; (3) respiratory rate greater than 20 breaths 
per minute or partial pressure of carbon dioxide (PaCO2) less than 32mmHg; (4) white 
blood cell count greater than 12,000 cells per cubic millimeter or less than 4,000 cells per 
cubic millimeter or immature myeloid (band) forms greater than 10% 1.  
Group 3: non-SIRS group. The patients in this group were not diagnosed with sepsis nor 
met the SIRS criteria during their ICU stay.  
 
 
 
54 
 The predictive performances of physiomarkers to distinguish sepsis patients from 
patients in the SIRS group and from the non-SIRS group were separately evaluated using 
group 2 and group 3, respectively. The primary outcome was the diagnosis of sepsis, 
while the presence of severe sepsis or septic shock was considered to be the secondary 
outcome.  
 Sepsis onset time was defined as the earliest time of sepsis diagnosis and was 
applied to all sepsis cases regardless of whether they progressed from sepsis to severe 
sepsis or septic shock within their ICU stay. For patients whose earliest sepsis diagnoses 
were severe sepsis or septic shock, the disease onset time was considered to be the time 
of the first diagnosis of severe sepsis or septic shock. The SIRS onset time was defined as 
the time when a patient met any two or more than two of the SIRS criteria.  
 Patients age less than 18 years, those with ICU length of stay less than 6 hours, or 
those without recorded values for any of the physiomarkers were excluded. Patients with 
an admission diagnosis of sepsis, severe sepsis, or septic shock were also excluded as the 
physiological measures we used to predict sepsis onset were not available for these 
patients. 
 
Data collection 
 Patient demographic information, physiological values, lab tests, diagnoses, 
multidisciplinary care plans, care givers’ notes including nursing assessment and critical 
care flow sheet records, care provider orders, and corresponding treatments, were 
recorded into the electronic medical record system by health care providers and were 
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collected for the entire unit stay. Patient demographic characteristics included age, 
gender, race, marital status, height, weight, body mass index, admission source, and 
admission diagnosis. Race was classified as white, black or other; admission source was 
classified as emergency department (ED), floor, operating room (OR), or other; 
admission diagnosis was categorized by organ system as well as by an operative and non-
operative diagnosis. Acute Physiology and Chronic Health Evaluation (APACHE) IV 
score, and one of its components, Acute Physiological Score (APS), (Cerner, Kansas 
City, MO) were calculated from data collected by the electronic medical record. 
Microsoft SQL server 2000 was used to extract patient information from the data server.  
 We obtained values and corresponding time of assessment for continuously 
monitored physiomarkers, including heart rate, respiratory rate, blood pressure, and 
temperature. In the electronic system, a patient’s physiological status and vital signs were 
measured, validated, and updated every 30 to 60 minutes during the initial 24 to 48 hours 
of their ICU stay and every 2 to 4 hours when a patient became relatively stable or was 
ready for ICU discharge.  
 Because we were interested in predicting the onset of sepsis, we only analyzed 
values recorded prior to sepsis onset. We compared the physiological parameters within 
24 hours, 12 hours, or 6 hours before sepsis onset among the different groups. For the 
SIRS only group, values recorded within 24 hours, 12 hours, and 6 hours after SIRS onset 
were used. Since patients in the non-SIRS group had no disease “onset time”, we used the 
values recorded within 24 hours, 12 hours, and 6 hours after ICU admission. 
Furthermore, as non-SIRS patients might have more abnormal physiomarkers during the 
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time close to ICU admission, we also used the values recorded between 24th hour and 30th 
hour after ICU admission, to assess the robustness of the results. 
 
Data validation 
 Since the investigated physiomarkers were automatically recorded into the 
electronic system, with the exception of temperature being manually entered, a validation 
algorithm was set up to detect and correct parameters with extreme or non-physiological 
values. First, a senior intensive care physician was consulted to generate a reference list 
of possible value ranges for each physiomarker based on his expertise (heart rate: 20 ~ 
360 beats per minute; temperature between 30 ~ 42 °C, respiratory rate: 3 ~ 55 breaths 
per minute; systolic blood pressure: 40 ~ 300 mmHg; and diastolic blood pressure: 20 ~ 
150 mmHg). Second, we checked the distribution of each physiomarker and compared 
the values lower than the 1st percentile or higher than the 99th percentile to the reference 
value ranges. We then identified patients with physiomarker values outside the reference 
range and reviewed their entire nursing care flowsheet. We made corrections to the 
problematic values: 1) if the values recorded right before and after the problematic values 
were all within the reference range, we replaced the problematic value by the mean of the 
two values recorded before and after; 2) if the temperature was inappropriately recorded 
in the Fahrenheit scale, we converted it to the Celsius scale; 3) problematic noninvasive 
blood pressures were compared to invasive blood pressure for patients with an arterial 
catheter. If the invasive blood pressure values were within the reference range, the 
problematic noninvasive blood pressure values were excluded from the analysis.  
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Statistical Analysis 
 Patient’s baseline demographic variables, admission diagnosis, and disease 
severity were summarized by calculating means and medians for continuous variables 
and frequencies for categorical variables. Differences between sepsis and SIRS patients 
or between sepsis and the non-SIRS patients were determined using t test, Wilcoxon rank 
sum test, chi square test or Fisher exact test, as appropriate. We first plotted the values o f 
the physiomarkers for all three groups of patients along the time axis for the 24 hours 
before sepsis onset. The purpose was to visually explore any correlation between clinical 
parameters’ value changes and sepsis onset. The patient population was rando mly divided 
into two subsets, two thirds in a “training set” in which the physiomarkers and prediction 
models are obtained, and the remaining one third in a “validation set” where the 
diagnostic performance of the parameter(s) and the model are evaluated. In this way, we 
could evaluate the parameter(s) or model fairly to avoid overfitting.  
 We evaluated the independent predictive ability of each physiomarker 
measurement (original value, mean, median, standard deviation, the division of standard 
deviation by mean, interquartile range, and range), trending, as well as the shock index 22 
(heart rate/systolic blood pressure), with sepsis onset, within the next 24 hours by 
performing a bivariate analysis. “Trending” was defined as the relationship of time and 
the changes in physiomarkers for each patient. To determine the trending for each patient, 
we fitted a Lowess curve for the values recorded within the 24 hours period using t ime as 
the independent variable and the physiomarker as the dependent variable. Estimated slope 
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coefficients were then generated and considered as the measurement of “trending”. 
Receiver operating characteristic (ROC) curves were constructed and the areas under the 
receiver operating characteristic curve (AUC) were calculated for the different 
measurements of each physiomarker. Their corresponding optimal cut-off points were 
determined by maximizing the Youden’s Index 23. We applied these optimal cut-off 
points to the validation set and assessed their predictive performance by calculating the 
sensitivities and specificities.  Candidates selected on the basis of the highest AUC values 
among the measurements of the investigated physiomarkers were the maximum values of 
temperature, respiratory rate, and heart rate, the minimum values of systolic and diastolic 
blood pressure, and shock index, which were all significantly associated with sepsis onset 
(p< 0.1). The measure of trending by estimated slope coefficient was also selected to be a 
candidate for multivariate regression analysis.  
 A series of multivariate logistic regression models were constructed in the 
training set including different combinations of the candidate variables. Correlation 
among predictors was examined by using Spearman’s correlation test. The “best” model 
was chosen based on the combination of characteristics of having one of the highest 
values of AUC and being a parsimonious model. Based on the model parameter estimates 
from the training set, we predicted the diagnosis of sepsis using the validation set. 
Prediction and discrimination performances of the models were determined by AUC.  
 The same process was carried out for subgroup analyses of patients with severe 
sepsis or septic shock. It was also applied to the parameters recorded within 24 hours, 12 
hours, or 6 hours before acute sepsis onset. A p value of 0.05 or less using 2-tailed tests 
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was considered as significant in the multivariate regression models. Statistical analysis 
was performed using Stata, version 10.0 (StataCorp LP, College Station, TX, USA).  
  
3.3 Results 
Patient Characteristics 
 After excluding 274 patients for whom values of physiological parameters were 
not available, the final analytic sample consisted of 14,466 ICU patients who were 
admitted at a single tertiary care medical center between October, 2007 and December, 
2009, included 1,917 sepsis patients, 10,370 SIRS only patients, and 2,179 non-SIRS 
patients. The mean age of the study subjects was between 62 to 65 years, and it varied 
across the three groups with the sepsis group significantly older than the other two 
groups. About 40% of the study subjects were female, and nearly 90% were white. 
Compared to the other two groups of patients, sepsis patients were less likely to be 
married at the time of ICU admission. In accordance with sepsis definition, sepsis 
patients had significantly higher acuity scores than SIRS or non-SIRS patients. Sepsis 
patients were more likely to have been transferred from other patient wards and less 
likely to have been transferred from an operating room. Sepsis patients more often had an 
admitting diagnosis of a gastrointestinal or respiratory disease (Table 3.1).  
 
Clinical Outcomes 
 Patients developing sepsis during their ICU stay stayed an average of 16.0 days in 
the hospital and 8.3 days in the ICU, which were significantly longer than those of SIRS 
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only (11.4 and 4.6 days respectively) or non-SIRS patients (5.6 and 1.6 days 
respectively). 34.3% of patients with sepsis died during their hospita lization and 26.9% 
of them died during their ICU stay; on the other hand, 8.9% and 12.5% of patients with 
SIRS died in an ICU or in the hospital, respectively. 96.9% of non-SIRS patients 
survived the hospital stay.  
 
Individual Parameter Time Patterns 
 The changes in individual parameters over time in three different time windows 
are depicted as Lowess curves (Figure 3.1 – 3.3). Compared to SIRS or non-SIRS 
patients, sepsis patients exhibited declining diastolic and systolic blood pressures which 
were much lower than those of the other two patient groups. Trends in heart rate, 
respiratory rate, and body temperature for sepsis patients either slightly increased or 
decreased over time, but they were constantly above those of SIRS or non-SIRS patients.   
 
Individual Parameter Performance on Discriminating Sepsis from SIRS  
 Overall, no individual parameter alone performed well in discriminating sepsis 
patients from SIRS patients, with the highest area under ROC curve being less than 0.75. 
Tables 3.2, 3.3, and 3.4 show the performance of individual parameters during 6-hour, 
12-hour, and 24-hour time windows prior to disease onset, respectively. Based on the 
validation set, minimum values of the two blood pressure parameters had a higher area 
under the ROC (ranging from 0.66 to 0.72) than that of median, maximum, inter-quartile 
range, mean, or standard deviation. It was the same case across all three time windows. 
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Heart rate did not show a consistent pattern across three time windows, with median, 
inter-quartile range, and maximum performing best in each of the time windows. The 
maximum value of temperature always performed better than other measures, with the 
area under the ROC curve varying from 0.58 to 0.63.  In two of the three time windows, 
the maximum value of respiratory rate demonstrated a better performance than the other 
measures. Finally, among the five routinely collected physiological parameters, diastolic 
blood pressure, systolic blood pressure, heart rate, temperature, and respiratory rate, 
systolic blood pressure performed best in discriminating sepsis patients from SIRS 
patients. This finding was consistent in all three time windows.  
 
Test Characteristics of Individual Parameters for Discriminating Sepsis from SIRS 
 Individual parameters had sub-optimal predictive ability for differentiating sepsis 
from SIRS in the validation set. The sensitivity and specificity of these parameters were 
less than 60% and 80%, respectively (Tables 3.2 – 3.4). The best measurement among the 
investigated physiological parameters was minimum systolic blood pressure (optimal 
cutoff point 86), yielding a sensitivity of 56% and a specificity of 78% in a 24-hour 
window, followed by maximum respiratory rate (optimal cutoff point 26) in a 24-hour 
window, with the sensitivity and specificity being 51% and 74%. In general, test 
characteristics were better in the 24-hour time window than the other time frames.  
 
Individual Parameter Performance for Discriminating Sepsis from non-SIRS 
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 As expected, individual parameters performed much better in comparing sepsis to 
non-SIRS than comparing sepsis to SIRS patients. As shown in Tables 3.5 – 3.7, heart 
rate had the largest area under the ROC curve among all individual parameters, varying 
between 0.87 and 0.89. Both the mean or maximum values of heart rate performed well 
in differentiating sepsis from non-SIRS patients. Mean diastolic blood pressure and 
minimum systolic blood pressure could more accurately classify sepsis patients than 
other measures such as median or maximum, but both parameters were no better than 
heart rate or respiratory rate. The area under the ROC curve of maximum temperature 
ranged from 0.71 to 0.80, and that of mean or maximum respiratory rate from 0.80 to 
0.84.  
 
Test Characteristics of Individual Parameters for Discriminating Sepsis from Non-SIRS 
 Maximum heart rate with a cutoff point of 90 can accurately classify sepsis from 
non-SIRS and achieved a sensitivity of 80% and a specificity of 89% in a 24-hour 
window (Table 3.7).  Maximum respiratory rate could also differentiate sepsis patients 
from non-SIRS patients fairly well, and its sensitivity and specificity were 73% and 85% 
in a 24-hour window. In contrast, the two blood pressure measures and temperature had 
relatively lower sensitivity and specificity in all three time windows. Parameters typically 
performed better in 24-hour windows compared to 6-hour or 12-hour windows.  
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Performance of Combined Parameters 
 The combination of all five parameters performed better than the individual 
parameters (Table 3.8 – 3.10); the longer the time window, the better the performance. In 
a 24-hour window, the area under ROC of the combination of five parameters reached 
0.76 for comparing sepsis to SIRS in the training set (Figure 3.4), and 0.74 in the 
validation set (Table 3.10).  When comparing sepsis to non-SIRS, the area under the 
curve reached 0.94 (Figure 3.5) in the training set and 0.90 in the validation set (Table 
3.10). Since diastolic blood pressure is less clinically relevant to sepsis diagnosis, we also 
tested removing it from the combination of the five parameters and found the area under 
ROC only slightly changed.  
 Compared to other combinations, the combination of the parameter slopes of 
change over time did poorly in differentiating sepsis from either SIRS or non-SIRS 
patients, as did the standardized mean (mean divided by standard deviation). The area 
under ROC curve was in a range of 0.50 and 0.66 for both combinations of parameters. 
Interestingly, the shock index, measured as the ratio of systolic blood pressure over heart 
rate, also did poorly in differentiating sepsis from SIRS patients. However, the shock 
index had an increased area under ROC curve (0.80 – 0.85) when comparing sepsis to 
non-SIRS cases.  
 
Test Characteristics of Combined Parameters 
 Based on the optimal cutoff point for each parameter, a patient was classified as 
having sepsis if at least one minimum measure of two blood pressure parameters was 
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abnormal and at least one maximum measure of the other three parameters was abnormal 
(Tables 3.8 – 3.10). In distinguishing sepsis from SIRS, the sensitivity was between 28% 
and 49%, and the specificity between 77% and 89%. For sepsis and non-SIRS patients, 
both the sensitivity and specificity were higher than those separating sepsis from SIRS, 
and the best combination showed a sensitivity of only 62% and a specificity of 77%. 
Other more restrictive criteria such as at least one abnormal minimum measure of two 
blood pressure parameters and at least two abnormal maximum measurements of the 
other three parameters resulted in much lower sensitivities but higher specificities (data 
not shown). 
 
Sensitivity Analyses 
 About 52% of the sepsis patients had severe sepsis or septic shock. The subgroup 
analysis among these patients showed that the predictive performance of physiological 
parameters for distinguishing severe sepsis or septic shock from the other conditions, 
including SIRS only or non-SIRS patients, was similar to that of identifying sepsis patient 
(including sepsis, severe sepsis, and septic shock). The sensitivity and specificity were 
slightly improved and yet the area under ROC curve was not significantly different from 
the latter (data not shown). In addition, compared to the results using the data within 6 
hours after ICU admission for the non-SIRS patients, those based on the data from 
between the 24th and 30th hour after admission did not change the main findings. The 
sensitivity and specificity of heart rate and temperature slightly increased; whereas, those 
of blood pressure parameters and respiratory rate declined (Appendix Table 3.1). The 
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performances of most comprehensive measures (except standardized mean) based on the 
24th-30th hour data for non-SIRS patients also slightly decreased compared to those in 
the main analysis (Appendix Table 3.2). 
  
3.4 Discussion 
 Although included in the definition of sepsis, and widely adopted by clinicians 
and routinely monitored in ICUs, physiological parameters, including heart rate, 
respiratory rate, blood pressure, and temperature, have generally been reported to have 
inferior diagnostic performance in identifying sepsis patients from SIRS or non-SIRS 
patients. In a study which evaluated the parameters included in SIRS criteria among 
patients with suspected infection in an emergency department, it was concluded that the 
SIRS criteria had little usefulness and correlated poorly with infection 21. In another study 
which analyzed the project IMPACT data set, collected from 94 hospitals and more than 
120 ICUs, the investigator reported that a model with heart rate, mean arterial pressure, 
temperature, and respiratory rate yielded a sensitivity of 59.4%, and a specificity of 
67.7% 19. Bossink et al. also reported very low specificity of the SIRS definition 20. 
Attempting to find a parameter that could facilitate clinicians making sepsis diagnosis, 
especially early diagnosis, most contemporary work focuses on more expensive 
laboratory test including c-reactive protein, procalcitonin, and gene-expression 
profiling.24, 25 
 Realizing that previous studies only included a limited number of values for the 
studied parameters, this study systematically collected all the values for the continuously 
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monitored physiological parameters from an electronic medical record system, and 
evaluated various parameter measurements, trends of parameters, and derived predictors 
including the shock index. We demonstrated that sepsis patients tended to be more 
physiologically disarranged as having higher heart rates, lower blood pressure, higher 
temperatures and higher respiratory rates, compared to SIRS or non-SIRS patients. More 
importantly, continuously monitored physiological parameters measured 24 hours before 
disease onset have improved performance for identifying sepsis from SIRS patients and 
excellent predictive accuracy for distinguishing sepsis from non-SIRS critically ill adult 
patients. For a single parameter, minimum systolic blood pressure and maximum heart 
rate recorded within 24 hours of the disease onset performed the best for identifying 
sepsis from SIRS or non-SIRS patients, with an area under the ROC curve 0.69 and 0.89, 
respectively; at the optimal cutoffs of 86 mmHg and 90 beats pre minutes, they had a 
sensitivity of 56% and 80%, and a specificity of 78% and 89%, respectively. The 
combination of these physiological parameters (the two minimum blood pressure 
parameters and the other three maximum parameters) achieved area under ROC curve of 
0.74 and 0.90 in differentiating sepsis from SIRS and non-SIRS patients, respectively, 
which were comparable to the published values of area under ROC curve reported for 
procalcitonin 10, 11. 
 To our knowledge, this is the first study on the usefulness of continuously 
monitored physiological parameters that are readily available in ICUs. This study has 
several innovative features in distinguishing sepsis from SIRS only or non-SIRS patients: 
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 First, we applied a longer period of continuously monitored physiological 
parameters to establish measurements that demonstrated improved predictive 
performance for these parameters. After collecting all the recorded values, we measured 
the characteristics and changes over time for each parameter by calculating the 
maximum, minimum, variance (standard deviation), inter-quartile range and trend over 
time (slope of fitted linear line). Candidate measures were chosen based on the highest 
values of area under ROC curve. Shock index has been reported to be an indicator of left 
ventricular function during critical illnesses. In the patient population of our ICUs, shock 
index was shown to be no better than other measures in predicting onset of sepsis. This 
may be due to the fact that early in the disease course, septic patients have normal left 
ventricular function; whereas, impaired left ventricular function can develops as sepsis 
advances. Moreover, other diseases, including hemorrhage and trauma, can also lead to 
suppressed left ventricular function 22. 
 Secondly, we were able to use values of physiological parameters that were 
recorded before sepsis was diagnosed. Along with the purpose of predicting sepsis onset 
among critically ill patients rather than comparing the differences in these parameters 
between sepsis and SIRS or non-SIRS, we demonstrated that patients experienced subtle 
physiological deteriorations before symptoms became clinically apparent and before a 
diagnosis of sepsis was made. In fact, being able to recognize these subtle changes by 
using the most sensitive measures of these physiological parameters would assist in 
identification of sepsis in its early stage. It would also allow interventions and treatment 
to be administrated in a more timely manner for these patients. Additionally, analyzing 
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values recorded before sepsis onset also ensured that the relationship between 
physiological symptoms and sepsis was not confounded by treatment or other 
interventions for sepsis. 
 Thirdly, we explored alternative time windows of 6-hour, 12-hour and 24-hour to 
determine the earliest time for predicting sepsis by comparing the parameter’s predictive 
performance. A challenge in clinical practice and research is that current definitions of 
sepsis do not provide corresponding time frame references for concurrence of the 
definitional criteria, especially in a longitudinal direction. For example, “a reduction in 
systolic blood pressure ≥ 40 mmHg from baseline” gives no information of a time 
perspective within which systolic blood pressure should be monitored and compared to 
its baseline value, and variance could exist within several hours, half a day, or even one 
day. Our approach of selecting the optimal time window provides clinicians and 
researchers a tangible, well defined observational time frame when they are reviewing or 
analyzing physiological parameters longitudinally. In our patient population, the 24-hour 
time window was the optimal one, which suggests that sub-acute physiological changes 
in sepsis patients could happen up to 24-hours before the syndromes became clinically 
apparent and sepsis was diagnosed. 
 The strengths of our study were that it was the first study to evaluate the 
usefulness of continuously monitored physiological parameters and their role for sepsis 
recognition and early diagnosis. Although laboratory tests and culture tests provide 
valuable information in confirming sepsis diagnosis, it is the deterioration in the 
commonly available monitored physiological changes that usually draws a clinician’s 
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attention and leads to subsequent diagnostic examination. Our study also demonstrated 
that among the investigated parameters, minimum systolic blood pressure and maximum 
heart rate had the highest diagnostic accuracy. Moreover, we were aware of the issue of 
overfitting and addressed it by randomly splitting the study population into a derivation 
set and a validation set.  
 It was counterintuitive that estimated slope coefficients, the measurement of 
“trending”, did not yield better performance compared to other combined measures, 
although sepsis patients did show a declining trend in diastolic and systolic blood 
pressure before disease onset. However, compared to SIRS or non-SIRS patients, blood 
pressure measures among sepsis patients were consistently lower, while heart rate, 
respiratory rate, and body temperature of sepsis patients were constantly higher. These 
findings serve as a caution against the over interpretation of trends for these physiological 
parameters. 
 Previous studies reported inconsistent performance of diagnostic tests which was 
partially due to mixed control populations. Critically ill patients with SIRS syndrome 
have an increased risk of developing sepsis compared to those not meeting SIRS criteria 
8. To address this concern, we examined the physiological parameters by comparing the 
changes between sepsis and non- infected SIRS and between sepsis and non-SIRS 
patients, respectively. As expected, the diagnostic performance was better for the latter.  
 Several limitations in our study merit consideration. First, our patients were from 
a single health care system, so the results of this study may not be generalizable. 
Secondly, although the combinations of the physiological parameters had good predictive 
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power, it was not sufficient to accurately predict who would develop sepsis within next 
24 hours. Instead, clinicians should integrate these physiological signs with other patient 
characteristics, underlying disease severity, and comorbidities, and initiate other 
diagnostic tests to determine if sepsis is present. Nonetheless, the physiological 
parameters we presented in this study could help clinicians recognize sepsis patients 
earlier before they progress into a more severe stage. Third, we focused on patients who 
developed sepsis during their ICU stay, so our results may not be applicable to patients in 
other settings or who are recognized as having sepsis at the time of ICU admission.  
  
3.5 Conclusions 
 The signs and symptoms of sepsis are highly variable and dynamic. Continuously 
monitored physiological parameters could help to identify patients who show signs of 
deterioration in the preceding 24 hours prior to being diagnosed as having sepsis. Our 
findings confirm prior studies that physiological parameters do not appear to be sepsis 
specific and had limited power of identifying patients with sepsis from non-infectious 
SIRS patients. However, the physiological parameters had excellent performances for 
distinguishing sepsis patient from non-SIRS patients in ICUs.   
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Table 3.1   Patient Characteristics 
Characteristics 
Sepsis Patients 
(n=1,917) 
SIRS Patients 
(n=10,370) 
Non-S IRS 
Patients 
(n=2,179) 
Age, mean ± SD 64.55±16.28 62.44±17.44** 63.12±16.36*  
Female Gender, n (%) 837(43.66) 4,415(42.57) 841(38.60)** 
Race n (%)       
    White  1,683(87.79) 9,266(89.35)* 1,924(88.30) 
    Black 68(3.55) 290(2.80) 69(3.17) 
    Other 166(8.66) 814(7.85) 186(8.54) 
Married Status n (%) 835(43.56) 4,866(46.92)* 1,178(54.06)** 
BMI, mean ± SD 28.84±8.30 28.84±29.93 28.32±8.45 
APS Score, mean ± SD 72.64±30.02 48.19±23.97** 32.27±14.90** 
APACHE Score, mean ± SD 86.07±31.55 59.76±26.04** 43.73±18.36** 
Admission Source, n (%)       
    Emergency Room 1,096(57.17) 5,486(52.90)** 1,389(63.74)** 
    Ward  391(20.40) 1,693(16.33)** 227(10.42)** 
    Operation Room 157(8.19) 2,189(21.11)** 369(16.93)** 
    Other Hospital 273(14.24) 919(8.86)** 132(6.06)** 
Operative Diagnosis, n (%) 132(6.89) 2,000(19.29)** 304(13.95)** 
Admission Diagnosis, n (%)       
    Cardiovascular  791(41.26) 3,298(31.80)** 882(40.48) 
    Gastrointestinal 282(14.71) 1,242(11.98)** 171(7.85)** 
    Respiratory  393(20.50) 1,708(16.47)** 106(4.86)** 
    Genitourinary  91(4.75) 218(2.10)** 28(1.28)** 
    Neurology 72(3.76) 1,762(16.99)** 601(27.58)** 
    Other 288(15.02) 2,142(20.66)** 391(17.94)* 
Clin ical Outcomes       
Hospital Length of Stay, mean ± SD 16.07±18.50 11.40±13.37** 5.57±6.96** 
ICU Length of Stay, mean ± SD 8.28±10.44 4.64±7.70** 1.56±1.20** 
Hospital Mortality 657(34.27) 1,297(12.51)** 67(3.07)** 
Unit Mortality 515(26.86) 924(8.91)** 33(1.51)** 
* p<0.05 compared to sepsis patients; ** p<0.01 compared to sepsis patients. 
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Table 3.2   Individual Parameter Performance Comparing Sepsis to SIRS in a 6-hour Window 
Parameter  
Area Under 
ROC Using 
Training Set 
Area Under 
ROC Using 
Validation Set 
Optimal 
Cutoff 
Point 
Sensitivity in 
Training Set 
Specificity in 
Training Set 
Sensitivity in 
Validation Set 
Specificity in 
Validation Set 
Diastolic 
Blood 
Pressure 
(Sepsis 
n=475; SIRS 
n=6,276) 
Minimum 0.6369 0.6660 45 43.0% 72.3% 45.4% 71.3% 
Median 0.6373 0.6484 53 42.7% 72.9% 44.2% 71.7% 
Maximum 0.6109 0.6218 63 46.1% 70.8% 46.2% 70.4% 
Inter Quarter Range  0.5252 0.4964 9 32.8% 60.2% 37.8% 59.6% 
Mean 0.6419 0.6601 53 42.5% 74.2% 44.6% 72.7% 
Standard Deviation 0.5482 0.4793 8 31.4% 56.0% 37.8% 55.6% 
Systolic 
Blood 
Pressure  
(Sepsis 
n=465; SIRS 
n=6,278) 
Minimum 0.6744 0.7210 94 44.5% 75.4% 56.0% 75.3% 
Median 0.6612 0.6892 107 46.7% 74.0% 54.1% 73.7% 
Maximum 0.6244 0.6299 120 45.6% 72.8% 46.7% 71.8% 
Inter Quarter Range  0.5325 0.5167 15 34.2% 66.3% 30.9% 67.6% 
Mean 0.6655 0.6929 107 46.7% 74.9% 52.1% 74.7% 
Standard Deviation 0.4975 0.4308 12 33.8% 61.5% 32.8% 62.9% 
Heart Rate  
(Sepsis 
n=462; SIRS 
n=6,294) 
Minimum 0.5439 0.5395 78 35.1% 60.0% 36.3% 61.2% 
Median 0.5687 0.5533 94 45.5% 68.5% 41.6% 66.2% 
Maximum 0.5511 0.5393 101 45.2% 67.5% 45.4% 64.9% 
Inter Quarter Range 0.5311 0.5040 7 35.9% 64.3% 36.3% 62.0% 
Mean 0.5623 0.5505 95 44.4% 68.4% 42.4% 66.5% 
Standard Deviation 0.5176 0.4981 6 32.7% 57.2% 30.2% 56.0% 
Temperature 
(Sepsis 
n=433; SIRS 
n=5,870) 
Minimum 0.5859 0.5784 37 52.4% 61.3% 49.0% 61.6% 
Median 0.5902 0.5803 37 61.7% 50.3% 58.6% 50.6% 
Maximum 0.5853 0.5827 38 22.6% 86.0% 25.1% 86.1% 
Inter Quarter Range  0.5209 0.5146 0 52.2% 52.7% 50.2% 52.8% 
Mean 0.5892 0.5822 37 61.7% 49.9% 59.4% 50.3% 
Standard Deviation 0.4968 0.4747 5 43.4% 53.0% 42.6% 53.0% 
Respiratory 
Rate (Sepsis 
n=488; SIRS 
n=6,124) 
Minimum 0.5902 0.5629 16 29.7% 59.6% 32.3% 61.1% 
Median 0.6133 0.5956 21 45.3% 74.3% 41.9% 73.1% 
Maximum 0.5912 0.5895 23 50.6% 66.9% 51.1% 66.5% 
Inter Quarter Range  0.4901 0.5004 3 34.0% 66.8% 31.9% 69.1% 
Mean 0.6079 0.5935 21 46.7% 72.6% 42.8% 71.8% 
Standard Deviation 0.4780 0.4404 3 29.3% 67.3% 29.3% 65.4% 
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Table 3.3   Individual Parameter Performance Comparing Sepsis to SIRS in a 12-hour Window 
Parameter  
Area Under 
ROC Using 
Training Set 
Area Under 
ROC Using 
Validation Set 
Optimal 
Cutoff Point 
Sensitivity in 
Training Set 
Specificity in 
Training Set 
Sensitivity in 
Validation Set 
Specificity in 
Validation Set 
Diastolic 
Blood 
Pressure 
(Sepsis 
n=357; SIRS 
n=5,764) 
Minimum 0.6261 0.6307 42 42.3% 71.8% 41.3% 71.7% 
Median 0.6399 0.6027 53 42.3% 73.1% 35.3% 72.2% 
Maximum 0.6178 0.5676 67 45.1% 70.5% 38.9% 70.9% 
Inter Quarter Range  0.5133 0.4995 10 34.7% 60.4% 36.5% 62.4% 
Mean 0.6493 0.6093 53 43.1% 74.5% 36.5% 73.7% 
Standard Deviation 0.5753 0.4885 9 30.3% 54.0% 35.9% 56.1% 
Systolic 
Blood 
Pressure 
(Sepsis 
n=350; SIRS 
n=5,772) 
Minimum 0.6655 0.6742 90 45.1% 74.4% 48.3% 75.9% 
Median 0.6507 0.6535 107 46.6% 73.1% 47.1% 74.5% 
Maximum 0.6035 0.5753 126 46.6% 70.1% 39.1% 71.4% 
Inter Quarter Range  0.5239 0.5328 16 35.4% 63.9% 35.1% 64.7% 
Mean 0.6555 0.6548 107 45.4% 74.1% 44.8% 75.1% 
Standard Deviation 0.5086 0.4460 13 36.0% 57.9% 39.7% 57.3% 
Heart Rate 
(Sepsis 
n=363; SIRS 
n=5,765) 
Minimum 0.5472 0.5221 75 32.8% 60.0% 37.3% 61.0% 
Median 0.5630 0.5465 94 43.3% 67.5% 42.2% 67.3% 
Maximum 0.5519 0.5639 105 45.7% 67.0% 43.5% 66.7% 
Inter Quarter Range  0.5160 0.5536 9 32.8% 66.9% 39.1% 67.0% 
Mean 0.5610 0.5507 95 43.0% 68.3% 42.2% 68.5% 
Standard Deviation 0.5411 0.4524 7 33.9% 54.7% 39.8% 56.5% 
Temperature 
(Sepsis 
n=324; SIRS 
n=5,639) 
Minimum 0.5782 0.5779 37 40.7% 71.3% 38.0% 74.9% 
Median 0.6134 0.5843 37 62.7% 52.3% 57.1% 53.8% 
Maximum 0.6280 0.6033 38 31.8% 83.9% 23.4% 84.5% 
Inter Quarter Range  0.5881 0.5584 1 13.3% 88.5% 13.6% 87.1% 
Mean 0.6151 0.5902 38 19.4% 91.5% 16.3% 92.8% 
Standard Deviation 0.4931 0.4410 1 6.5% 77.4% 12.5% 75.1% 
Respiratory 
Rate  (Sepsis 
n=358; SIRS 
n=5,666) 
Minimum 0.5650 0.5549 15 31.3% 59.2% 33.5% 60.9% 
Median 0.6242 0.6148 21 42.2% 75.2% 50.0% 73.8% 
Maximum 0.6053 0.6400 25 42.5% 73.4% 50.6% 72.9% 
Inter Quarter Range  0.5110 0.5325 3 38.3% 64.4% 42.7% 64.8% 
Mean 0.6160 0.6131 21 42.2% 72.9% 53.1% 71.5% 
Standard Deviation 0.5027 0.5279 3 36.6% 63.0% 42.1% 64.4% 
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Table 3.4   Individual Parameter Performance Comparing Sepsis to SIRS in a 24-hour Window 
Parameter  
Area Under 
ROC Using 
Training Set 
Area Under 
ROC Using 
Validation Set 
Optimal 
Cutoff Point 
Sensitivity in 
Training Set 
Specificity in 
Training Set 
Sensitivity in 
Validation Set 
Specificity in 
Validation Set 
Diastolic 
Blood 
Pressure   
(Sepsis 
n=213; SIRS 
n=4,942) 
Minimum 0.6384 0.6440 40 42.2% 72.3% 50.9% 73.9% 
Median 0.6184 0.6257 53 38.8% 73.0% 47.4% 73.7% 
Maximum 0.5520 0.5608 71 44.6% 67.3% 42.1% 66.9% 
Inter Quarter Range  0.5223 0.5269 11 25.6% 60.9% 28.1% 62.5% 
Mean 0.6276 0.6310 53 41.3% 75.0% 42.1% 74.5% 
Standard Deviation 0.5583 0.5232 10 25.6% 56.8% 28.1% 57.9% 
Systolic 
Blood 
Pressure   
(Sepsis 
n=217; SIRS 
n=4,938) 
Minimum 0.6907 0.6934 86 49.6% 77.7% 55.6% 77.8% 
Median 0.6341 0.6351 107 49.6% 74.7% 49.2% 73.1% 
Maximum 0.5565 0.5426 131 42.6% 68.0% 34.9% 66.7% 
Inter Quarter Range  0.5285 0.5210 18 34.8% 65.3% 44.4% 66.7% 
Mean 0.6410 0.6376 107 48.7% 76.2% 41.3% 74.1% 
Standard Deviation 0.5028 0.4550 14 36.5% 57.0% 50.8% 58.3% 
Heart Rate   
(Sepsis 
n=220; SIRS 
n=4,942) 
Minimum 0.4902 0.5249 74 37.0% 60.0% 33.3% 59.3% 
Median 0.5579 0.5179 96 45.0% 70.0% 35.9% 70.4% 
Maximum 0.5969 0.5754 110 48.0% 71.3% 47.4% 70.4% 
Inter Quarter Range  0.5406 0.5977 10 44.0% 65.7% 37.2% 67.3% 
Mean 0.5534 0.5210 97 44.0% 69.5% 34.6% 70.1% 
Standard Deviation 0.5150 0.4989 8 37.0% 57.5% 43.6% 60.2% 
Temperature   
(Sepsis 
n=220; SIRS 
n=4,835) 
Minimum 0.5861 0.5119 37 24.6% 78.2% 40.7% 77.2% 
Median 0.6515 0.5846 37 67.2% 52.4% 70.4% 53.3% 
Maximum 0.6916 0.6315 38 39.3% 81.9% 46.3% 82.8% 
Inter Quarter Range  0.5781 0.5656 1 16.4% 86.9% 14.8% 87.6% 
Mean 0.6592 0.5888 38 14.8% 92.2% 29.6% 92.1% 
Standard Deviation 0.5322 0.4717 1 7.4% 80.0% 3.7% 79.7% 
Respiratory 
Rate (Sepsis 
n=208; SIRS 
n=4,873) 
Minimum 0.4929 0.5207 14 36.6% 68.3% 30.3% 68.3% 
Median 0.6121 0.6324 21 46.4% 74.2% 47.0% 74.3% 
Maximum 0.6529 0.6706 26 51.8% 73.7% 51.5% 74.3% 
Inter Quarter Range  0.5473 0.5702 3 47.3% 61.1% 42.4% 61.5% 
Mean 0.6078 0.6230 21 48.2% 71.5% 47.0% 71.8% 
Standard Deviation 0.5584 0.5532 3 45.5% 60.1% 39.4% 60.7% 
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Table 3. 5 Individual Parameter Performance Comparing Sepsis to Non-SIRS in a 6-hour Window 
Parameter  
Area Under 
ROC Using 
Training Set 
Area Under 
ROC Using 
Validation Set 
Optimal 
Cutoff Point 
Sensitivity in 
Training Set 
Specificity in 
Training Set 
Sensitivity in 
Validation Set 
Specificity in 
Validation Set 
Diastolic 
Blood 
Pressure 
(Sepsis n=475; 
non-SIRS 
n=1,381) 
Minimum 0.6944 0.6351 45 46.7% 76.4% 38.6% 71.3% 
Median 0.6912 0.6553 53 46.9% 77.9% 36.7% 77.5% 
Maximum 0.6703 0.6315 64 49.9% 74.6% 44.8% 75.0% 
Inter Quarter Range  0.5636 0.5717 9 34.6% 56.0% 34.4% 57.2% 
Mean 0.7029 0.6565 54 51.6% 77.3% 42.9% 76.6% 
Standard Deviation 0.5384 0.5446 8 32.9% 62.8% 34.8% 61.9% 
Systolic 
Blood 
Pressure 
(Sepsis n=465; 
non-SIRS 
n=1,381) 
Minimum 0.7384 0.7121 95 53.6% 79.7% 48.7% 79.9% 
Median 0.7207 0.6993 107 51.2% 79.8% 49.4% 79.5% 
Maximum 0.6765 0.6564 122 50.1% 75.6% 49.8% 74.9% 
Inter Quarter Range  0.5116 0.5251 15 33.8% 64.1% 31.7% 64.8% 
Mean 0.7262 0.7053 108 51.2% 78.5% 53.7% 77.8% 
Standard Deviation 0.5198 0.5138 11 41.7% 62.9% 38.6% 64.8% 
Heart Rate 
(Sepsis n=465; 
non-SIRS 
n=1,381) 
Minimum 0.8272 0.8483 69 19.6% 34.0% 18.2% 31.1% 
Median 0.8428 0.8645 82 66.7% 87.8% 67.2% 89.7% 
Maximum 0.8493 0.8645 88 67.5% 87.8% 71.8% 88.3% 
Inter Quarter Range  0.5534 0.5510 6 42.4% 63.3% 43.2% 64.6% 
Mean 0.8463 0.8688 82 67.3% 87.9% 69.1% 89.2% 
Standard Deviation 0.5818 0.5891 5 43.0% 69.6% 44.8% 70.3% 
Temperature 
(Sepsis n=455; 
non-SIRS 
n=1,210) 
Minimum 0.6876 0.6885 37 43.7% 88.8% 40.2% 92.5% 
Median 0.7015 0.7088 38 26.8% 98.1% 24.9% 99.2% 
Maximum 0.7023 0.7141 37 48.6% 85.0% 52.4% 87.8% 
Inter Quarter Range  0.5418 0.5351 0 52.5% 54.9% 49.3% 55.7% 
Mean 0.7022 0.7080 37 70.1% 56.9% 69.9% 59.2% 
Standard Deviation 0.5489 0.4772 1 43.5% 50.8% 46.3% 48.7% 
Respiratory 
Rate (Sepsis 
n=463; non-
SIRS n=1,368) 
Minimum 0.7670 0.7517 15 25.3% 39.4% 24.4% 39.9% 
Median 0.7935 0.7992 18 64.4% 82.5% 65.8% 84.5% 
Maximum 0.7937 0.8008 21 63.9% 86.2% 64.2% 88.0% 
Inter Quarter Range  0.5144 0.5132 2 44.9% 58.0% 46.1% 60.8% 
Mean 0.8013 0.8017 18 68.9% 80.2% 67.3% 81.6% 
Standard Deviation 0.5710 0.5722 2 51.6% 65.2% 51.2% 64.1% 
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Table 3.6   Individual Parameter Performance Comparing Sepsis to non-SIRS in a 12-hour Window 
Parameter  
Area Under 
ROC Using 
Training Set 
Area Under 
ROC Using 
Validation Set 
Optimal 
Cutoff Point 
Sensitivity in 
Training Set 
Specificity in 
Training Set 
Sensitivity in 
Validation Set 
Specificity in 
Validation 
Set 
Diastolic Blood 
Pressure (Sepsis 
n=350; non-
SIRS n=1,327) 
Minimum 0.6545 0.5951 43 46.6% 73.3% 40.8% 68.3% 
Median 0.6626 0.6200 54 46.0% 75.7% 40.8% 72.6% 
Maximum 0.6362 0.6137 68 43.7% 73.4% 48.9% 73.8% 
Inter Quarter Range  0.5478 0.5530 10 34.3% 57.7% 37.4% 58.3% 
Mean 0.6705 0.6293 54 47.4% 75.5% 43.1% 72.9% 
Standard Deviation 0.5465 0.5551 9 31.7% 64.2% 32.8% 61.5% 
Systolic Blood 
Pressure (Sepsis 
n=350; non-
SIRS n=1,327) 
Minimum 0.7145 0.6715 91 50.9% 79.2% 45.4% 77.4% 
Median 0.7021 0.6497 108 52.0% 77.2% 39.1% 79.1% 
Maximum 0.6339 0.6001 128 52.3% 71.9% 39.1% 73.6% 
Inter Quarter Range  0.4937 0.4825 16 35.4% 62.8% 35.1% 61.0% 
Mean 0.7026 0.6552 108 50.6% 78.0% 39.1% 81.2% 
Standard Deviation 0.5128 0.5428 12 37.7% 64.9% 44.8% 62.9% 
Heart Rate 
(Sepsis n=343; 
non-SIRS 
n=1,335) 
Minimum 0.8467 0.8333 67 18.1% 30.0% 21.0% 29.9% 
Median 0.8604 0.8631 81 69.1% 89.5% 69.1% 90.5% 
Maximum 0.8645 0.8667 89 72.6% 87.9% 73.5% 87.6% 
Inter Quarter Range  0.5616 0.5744 8 42.6% 70.9% 39.8% 71.7% 
Mean 0.8660 0.8667 81 70.6% 88.8% 69.1% 90.0% 
Standard Deviation 0.5996 0.6060 6 46.1% 71.0% 42.0% 71.3% 
Temperature 
(Sepsis n=350; 
non-SIRS 
n=1,298) 
Minimum 0.6514 0.6865 37 33.1% 93.9% 34.8% 93.6% 
Median 0.7006 0.7352 38 28.9% 97.7% 33.5% 97.1% 
Maximum 0.7373 0.7659 38 28.3% 99.4% 25.3% 99.6% 
Inter Quarter Range  0.5927 0.5821 1 14.0% 93.5% 12.0% 93.9% 
Mean 0.7098 0.7476 38 35.1% 96.5% 33.5% 97.0% 
Standard Deviation 0.5746 0.5161 1 9.4% 87.8% 7.0% 87.2% 
Respiratory 
Rate (Sepsis 
n=336; non-
SIRS n=1,334) 
Minimum 0.7427 0.6919 14 22.3% 45.6% 29.0% 45.3% 
Median 0.8250 0.7728 18 67.3% 85.5% 63.4% 83.6% 
Maximum 0.8273 0.8005 22 66.1% 88.3% 62.9% 85.4% 
Inter Quarter Range  0.5513 0.5350 3 39.6% 76.3% 39.8% 77.2% 
Mean 0.8317 0.7709 19 64.6% 89.5% 56.5% 88.0% 
Standard Deviation 0.6299 0.6439 2 61.6% 57.9% 63.4% 59.2% 
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Table 3.7 Individual Parameter Performance Comparing Sepsis to Non-SIRS in a 24-hour Window 
Parameter  
Area Under 
ROC Using 
Training Set 
Area Under 
ROC Using 
Validation Set 
Optimal 
Cutoff Point 
Sensitivity in 
Training Set 
Specificity in 
Training Set 
Sensitivity in 
Validation Set 
Specificity in 
Validation Set 
Diastolic 
Blood 
Pressure 
(Sepsis 
n=222; non-
SIRS n=902) 
Minimum 0.5826 0.5954 39 36.0% 70.2% 40.5% 70.0% 
Median 0.6341 0.6361 54 43.7% 73.8% 39.7% 74.6% 
Maximum 0.6247 0.6242 74 47.8% 72.5% 50.0% 73.3% 
Inter Quarter Range 0.5706 0.6212 11 30.2% 60.2% 26.2% 58.3% 
Mean 0.6379 0.6429 55 47.8% 74.0% 43.7% 72.4% 
Standard Deviation 0.5808 0.5806 9 37.8% 52.3% 38.9% 46.6% 
Systolic 
Blood 
Pressure 
(Sepsis 
n=222; non-
SIRS n=902) 
Minimum 0.6729 0.6978 88 49.1% 75.4% 51.6% 76.4% 
Median 0.6629 0.6612 110 52.3% 74.2% 49.2% 72.9% 
Maximum 0.5850 0.6162 135 46.4% 69.2% 44.4% 68.7% 
Inter Quarter Range  0.4855 0.4619 18 37.4% 63.2% 32.5% 68.7% 
Mean 0.6639 0.6678 109 49.6% 75.5% 50.0% 75.1% 
Standard Deviation 0.5111 0.5009 14 37.8% 65.2% 38.1% 65.8% 
Heart Rate 
(Sepsis 
n=222; non-
SIRS n=902) 
Minimum 0.8455 0.8220 63 16.7% 32.7% 19.1% 36.4% 
Median 0.8758 0.8627 79 72.5% 90.1% 73.0% 88.7% 
Maximum 0.8786 0.8943 90 78.8% 90.2% 80.2% 88.5% 
Inter Quarter Range  0.5799 0.6370 9 41.4% 71.5% 53.2% 73.7% 
Mean 0.8804 0.8713 79 75.7% 89.4% 74.6% 87.6% 
Standard Deviation 0.6250 0.6679 7 46.0% 75.2% 51.6% 75.5% 
Temperature 
(Sepsis 
n=220; non-
SIRS n=894) 
Minimum 0.6534 0.6908 37 42.7% 85.6% 51.3% 89.3% 
Median 0.7328 0.7907 37 51.4% 88.4% 63.3% 91.0% 
Maximum 0.7719 0.8005 38 62.3% 79.0% 70.1% 83.6% 
Inter Quarter Range  0.5776 0.6189 1 10.0% 96.2% 16.2% 95.0% 
Mean 0.7403 0.7941 38 38.2% 96.8% 45.3% 98.9% 
Standard Deviation 0.6167 0.6501 1 4.6% 98.9% 6.8% 99.1% 
Respiratory 
Rate (Sepsis 
n=228; non-
SIRS n=893) 
Minimum 0.6857 0.6236 13 28.1% 51.4% 39.2% 51.5% 
Median 0.7937 0.7839 18 66.2% 82.4% 65.8% 81.0% 
Maximum 0.8120 0.8387 23 70.2% 85.6% 73.3% 84.5% 
Inter Quarter Range  0.5584 0.5880 3 48.7% 70.3% 52.5% 68.8% 
Mean 0.7969 0.7944 19 65.8% 87.4% 60.8% 85.6% 
Standard Deviation 0.6696 0.6991 3 44.7% 88.1% 49.2% 86.9% 
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Table 3.8   Performance of Combined Parameters in a 6-hour Window 
Parameter Measure 
Area Under ROC Compared to SIRS * Area Under ROC Compared to Non-SIRS ** 
Training Set Validation Set Training Set Validation Set 
Diastolic Blood Pressure Minimum 
0.7096 0.6906 0.9062 0.9260 
Systolic Blood Pressure Minimum 
Heart Rate Maximum 
Temperature  Maximum 
Respiratory Rate  Maximum 
Systolic Blood Pressure Minimum 
0.7079 0.7139 0.8985 0.9221 
Heart Rate Maximum 
Temperature  Maximum 
Respiratory Rate  Maximum 
Diastolic Blood Pressure 
Slope of Parameter 
Change Over Time 
0.5928 0.6152 0.6313 0.6630 
Systolic Blood Pressure 
Heart Rate 
Temperature  
Respiratory Rate  
Diastolic Blood Pressure 
Mean/Standard 
Deviation  
0.5816 0.5464 0.5972 0.5280 
Systolic Blood Pressure 
Heart Rate 
Temperature  
Respiratory Rate  
Systolic Blood Pressure Systolic Blood 
Pressure/Heart Rate 0.6462 0.6199 0.8487 0.8501 Heart Rate 
Diastolic Blood Pressure Minimum***  Train ing Set: Validation Set: Train ing Set: Validation Set: 
Systolic Blood Pressure Minimum***  
Sensitivity=26.4% Sensitivity=28.3%  Sensitivity=40.4%      Sensitivity=42.0%      Heart Rate Maximum***  
Temperature  Maximum***  
Specificity=89.2% Specificity=89.1%      Specificity=92.2%      Specificity=93.0%      
Respiratory Rate  Maximum***  
*There are 451 sepsis cases and 5791 SIRS cases in the training set, 226 sepsis cases and 2879 SIRS cases in the validation set. 
**There are 451 sepsis cases and 1204 other cases in the training set, 226 sepsis cases and 625 other cases in the validation set. 
*** Based on the optimal cutoff points, at least one abnormal blood pressure measure and at least one other abnormal measure.  
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Table 3. 9   Performance of Combined Parameters in a 12-hour Window 
Parameter  Measure 
Area Under ROC Compared to SIRS * Area Under ROC Compared to Non-SIRS ** 
Training Set Validation Set Training Set Validation Set 
Diastolic Blood Pressure Minimum 
0.7012 0.7094 0.9150 0.9286 
Systolic Blood Pressure Minimum 
Heart Rate Maximum 
Temperature  Maximum 
Respiratory Rate  Maximum 
Systolic Blood Pressure Minimum 
0.7003 0.7068 0.9114 0.9177 
Heart Rate Maximum 
Temperature  Maximum 
Respiratory Rate  Maximum 
Diastolic Blood Pressure 
Slope of Parameter Change Over 
Time 
0.5999 0.5678 0.6181 0.6425 
Systolic Blood Pressure 
Heart Rate 
Temperature  
Respiratory Rate  
Diastolic Blood Pressure 
Mean/Standard Deviation 0.6153 0.5007 0.5807 0.5190 
Systolic Blood Pressure 
Heart Rate 
Temperature  
Respiratory Rate  
Systolic Blood Pressure 
Systolic Blood Pressure/Heart Rate  0.6284 0.6051 0.8465 0.8331 
Heart Rate 
Diastolic Blood Pressure Minimum*** Train ing Set: Validation Set: Train ing Set: Validation Set: 
Systolic Blood Pressure Minimum*** 
Sensitivity=38.7% Sensitivity=35.2%      Sensitivity=53.5% Sensitivity=43.2% 
Heart Rate Maximum*** 
Temperature  Maximum*** 
Specificity=81.7%   Specificity=82.7%      Sensitivity=88.0% Sensitivity=86.0% 
Respiratory Rate  Maximum*** 
*There are 344 sepsis cases and 5,505 SIRS cases in the training set, 162 sepsis cases and 2,792 SIRS cases in the validation set. 
**There are 344 sepsis cases and 1299 other cases in the training set, 162 sepsis cases and 680 other cases in the validation set. 
***Based on the optimal cutoff points, at least one abnormal blood pressure measure and at least one other abnormal measure 
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Table 3.10   Performance of Combined Parameters in a 24-hour Window 
Parameter  Measure Area Under ROC Compared to SIRS
* Area Under ROC Compared to Non-SIRS ** 
Training Set Validation Set Training Set Validation Set 
Diastolic Blood Pressure Minimum 
0.7560 0.7442 0.9383 0.8992 
Systolic Blood Pressure Minimum 
Heart Rate Maximum 
Temperature  Maximum 
Respiratory Rate  Maximum 
Systolic Blood Pressure Minimum 
0.7555 0.7436 0.9342 0.8971 
Heart Rate Maximum 
Temperature  Maximum 
Respiratory Rate  Maximum 
Diastolic Blood Pressure 
Slope of 
Parameter 
Change Over 
Time 
0.6005 0.6078 0.5635 0.6495 
Systolic Blood Pressure 
Heart Rate 
Temperature  
Respiratory Rate  
Diastolic Blood Pressure 
Mean/Standard 
Deviation  
0.5938 0.5159 0.6585 0.5882 
Systolic Blood Pressure 
Heart Rate 
Temperature  
Respiratory Rate  
Systolic Blood Pressure Systolic Blood 
Pressure/Heart 
Rate 
0.6119 0.6005 0.8344 0.8089 
Heart Rate 
Diastolic Blood Pressure Minimum*** Train ing Set: Validation Set: Train ing Set: Validation Set: 
Systolic Blood Pressure Minimum*** 
Sensitivity=48.2%      Sensitivity=48.6%      Sensitivity=59.6% Sensitivity=62.4%      Heart Rate Maximum*** 
Temperature  Maximum*** 
Specificity=77.8%      Specificity=77.4%      Sensitivity=77.5% Sensitivity=77.3%      
Respiratory Rate  Maximum*** 
*There are 228 sepsis cases and 4,738 SIRS cases in the training set, 109 sepsis cases and 2,385 SIRS cases in the validation set. 
**There are 228 sepsis cases and 883 other cases in the training set, 109 sepsis cases and 463 other cases in the validation set. 
***Based on the optimal cutoff points, at least one abnormal blood pressure measure and at least one other abnormal measure.  
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Appendix Table 3.1   Individual Parameter Performance Comparing Sepsis to Non-SIRS in a 6-hour Window (24th-30th hour data for non-SIRS) 
Parameter  
Area Under 
ROC Using 
Training Set 
Area Under 
ROC Using 
Validation Set 
Optimal 
Cutoff Point 
Sensitivity in 
Training Set 
Specificity in 
Training Set 
Sensitivity in 
Validation Set 
Specificity in 
Validation Set 
Diastolic 
Blood 
Pressure 
(Sepsis 
n=481; non-
SIRS n=690) 
Minimum 0.6281 0.6482 44 40.3% 73.3% 42.8% 73.1% 
Median 0.6282 0.6266 53 43.9% 72.3% 42.0% 70.8% 
Maximum 0.5965 0.5896 63 46.8% 71.3% 44.9% 66.6% 
Inter Quarter Range  0.5580 0.5225 10 32.0% 60.9% 27.6% 64.9% 
Mean 0.6328 0.6314 53 45.3% 72.9% 43.6% 70.0% 
Standard Deviation 0.5458 0.4985 8 33.7% 60.4% 33.3% 64.0% 
Systolic 
Blood 
Pressure 
(Sepsis 
n=481; non-
SIRS n=690) 
Minimum 0.7051 0.7327 95 50.5% 78.1% 54.3% 78.2% 
Median 0.6841 0.6924 107 51.1% 77.0% 45.7% 78.5% 
Maximum 0.6054 0.6275 120 46.0% 69.9% 46.1% 72.2% 
Inter Quarter Range  0.5187 0.5119 14 36.8% 64.2% 37.5% 61.8% 
Mean 0.6784 0.6964 107 48.9% 76.8% 48.2% 81.0% 
Standard Deviation 0.5517 0.5425 11 40.8% 66.7% 40.3% 66.0% 
Heart Rate 
(Sepsis 
n=481; non-
SIRS n=690) 
Minimum 0.8550 0.8458 68 18.1% 31.9% 14.4% 32.3% 
Median 0.8758 0.8698 79 71.7% 89.6% 74.1% 86.7% 
Maximum 0.8857 0.8716 86 71.5% 89.6% 71.6% 89.0% 
Inter Quarter Range  0.5926 0.5596 6 44.1% 68.1% 39.9% 70.0% 
Mean 0.8794 0.8738 79 71.7% 89.3% 74.5% 85.3% 
Standard Deviation 0.6029 0.5939 5 44.1% 70.4% 42.8% 73.9% 
Temperature 
(Sepsis 
n=464; non-
SIRS n=601) 
Minimum 0.6591 0.6518 37 46.6% 87.5% 38.6% 92.0% 
Median 0.6876 0.6855 38 27.2% 98.3% 23.2% 99.4% 
Maximum 0.7038 0.7125 37 60.6% 76.7% 55.9% 81.8% 
Inter Quarter Range  0.5925 0.6363 0 50.0% 66.6% 54.6% 68.7% 
Mean 0.6878 0.6851 38 27.2% 98.3% 26.4% 98.4% 
Standard Deviation 0.5855 0.4001 1 46.3% 38.8% 40.5% 36.7% 
Respiratory 
Rate (Sepsis 
n=470; non-
SIRS n=688) 
Minimum 0.7123 0.7213 15 25.7% 50.2% 23.5% 53.7% 
Median 0.7545 0.7412 19 61.1% 82.6% 59.1% 81.2% 
Maximum 0.7700 0.7339 21 65.7% 81.7% 60.7% 76.8% 
Inter Quarter Range  0.5328 0.4590 2 47.9% 59.0% 40.5% 56.6% 
Mean 0.7584 0.7492 19 62.3% 81.3% 60.3% 78.3% 
Standard Deviation 0.5837 0.5111 2 54.7% 63.5% 45.3% 60.7% 
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 Appendix Table 3. 2   Performance of Combined Parameters in a 6-hour Window (24th-30th hour data for non-SIRS) 
Parameter Measure 
Area Under ROC Compared to SIRS * Area Under ROC Compared to Non-SIRS ** 
Training Set Validation Set Training Set Validation Set 
Diastolic Blood Pressure Minimum 
0.7096 0.6906 0.9163 0.9206 
Systolic Blood Pressure Minimum 
Heart Rate Maximum 
Temperature  Maximum 
Respiratory Rate  Maximum 
Systolic Blood Pressure Minimum 
0.7079 0.7139 0.9133 0.9185 
Heart Rate Maximum 
Temperature  Maximum 
Respiratory Rate  Maximum 
Diastolic Blood Pressure 
Slope of Parameter 
Change Over Time 
0.5928 0.6152 0.5632 0.5636 
Systolic Blood Pressure 
Heart Rate 
Temperature  
Respiratory Rate  
Diastolic Blood Pressure 
Mean/Standard 
Deviation  
0.5816 0.5464 0.6160 0.5895 
Systolic Blood Pressure 
Heart Rate 
Temperature  
Respiratory Rate  
Systolic Blood Pressure Systolic Blood 
Pressure/Heart Rate 
0.6462 0.6199 0.8653 0.8486 
Heart Rate 
Diastolic Blood Pressure Minimum***  Train ing Set: Validation Set: Train ing Set: Validation Set: 
Systolic Blood Pressure Minimum***  
Sensitivity=26.4% Sensitivity=28.3%  Sensitivity=40.4% Sensitivity=  42.0% Heart Rate Maximum***  
Temperature  Maximum***  
Specificity=89.2% Specificity=89.1%      Specificity=91.7% Specificity= 95.0% 
Respiratory Rate  Maximum***  
*There are 451 sepsis cases and 5791 SIRS cases in the training set, 226 sepsis cases and 2879 SIRS cases in the validation set. 
**There are 451 sepsis cases and 601 other cases in the training set, 226 sepsis cases and 301 other cases in the validation set. 
*** Based on the optimal cutoff points, at least one abnormal blood pressure measure and at least one other abnormal measure.  
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Figure 3.1   Individual Measure Time Patterns in a 6-hour Window 
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Figure 3.2   Individual Measure Time Patterns in a 12-hour Window 
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Figure 3.3   Individual Measure Time Patterns in a 24-hour Window 
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Figure 3.4   ROC Curve Based on the Model Using All Five Continuous Measures, 
Compared to SIRS Patients 
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Figure 3.5 ROC Curve Based on the Model Using All Five Continuous Measures, 
Compared to Other Non-SIRS Patients 
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Chapter IV Corticosteroid Treatment among Septic Shock 
Patients 
 
Aim 3: 
 
The Effectiveness of Corticosteroid Treatment on Septic Shock Patient Outcomes  in 
Intensive Care Units  
 
Abstract 
Background 
 Septic shock is a deadly disease with an unfortunately high mortality. The effect 
of prolonged moderate-dose corticosteroid replacement therapy on mortality in septic 
shock patients remains controversial.  
 
Objectives 
 To provide insight into the effects of low dose corticosteroids treatment as applied 
in clinical practice, we conducted this study by examining the use of corticosteroids 
treatment as well as its association with mortality in a large cohort of septic shock 
patients. 
 
Study Design 
 Data were collected from 841 consecutive septic shock adult patients admitted 
into seven ICUs between October 2007 and December 2009. We calculated a propensity 
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score for each patient to adjust for treatment selection bias. Differences in hospital and 
ICU mortality were evaluated using the McNemar test between propensity score matched 
pairs. The association of corticosteroid therapy with hospital mortality and ICU mortality 
were also determined using multivariate logistic regression after adjustment for 
propensity score alone, covariates, or propensity score (in deciles) and covariates.  
 
Results 
 Of the 841 septic shock patients, 698 (83 %) had septic shock at ICU admission or 
shock onset within the initial 24 hours after unit admission, and a total of 34% of (290 out 
of 841) patients received corticosteroid therapy. Propensity scores of 279 patients 
receiving low-dose corticosteroids were successfully matched with 279 patients without 
low-dose corticosteroids treatment. ). For matched pairs, significantly increased hospital 
mortality and ICU mortality were observed in the group treated with low-dose 
corticosteroids than the control group, OR was 1.44 (95% CI: 1.01, 2.08) and 1.57 (95% 
CI: 1.07, 2.32), respectively. Multivariate logistic regression after adjustment for 
propensity score alone, covariates, or propensity score (in deciles) and covariates 
generated similar results. Subgroup analyses showed a consistent, non-significant trend 
that patients receiving corticosteroids were associated with a higher mortality by divided 
patients by acuity, septic shock onset time, and treated with vasopressors, etomidate, or 
low-dose corticosteroid treatment initiated within 8, 24, or 72 hours or later after shock 
onset.  
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Conclusions 
 No survival benefits were identified in septic shock patients receiving low-dose 
corticosteroids. The results hold for all of the investigated subgroups across levels of 
disease severity, early or late onset during ICU stay, the timing of corticosteroids 
administration, and treatment with vasopressors or etomidate.
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4.1 Introduction 
 Septic shock is the most common cause of death in Intensive Care Units (ICUs), 
with a mortality rate ranging from 30% to 60% 1-3. Patients with septic shock fail to 
maintain hemodynamic homeostasis and develop abnormalities in circulation, which 
include increased vascular permeability, decreased intravascular volume, vasodilatation 
and myocardial depression, and imbalances of oxygen demand, extraction and delivery. It 
is thought that an intact adrenal cortex and adequate production of cortisol contributes to 
host ability to survive sepsis4. Additionally, increasing evidence has shown that critically 
ill patients develop adrenal insufficiency, referred to as critical illness-related 
corticosteroid insufficiency (CIRCI), with a prevalence of up to 60% in patients with 
septic shock5.  
 Since the introduction of corticosteroids as an adjunctive therapy in severe sepsis 
and septic shock a half century ago, its therapeutic role, in terms of efficacy and safety, 
has been debated. Although it is widely recognized that a short course of high dose 
corticosteroids is ineffective 6-9, whether prolonged moderate-dose corticosteroid 
replacement therapy improves mortality in septic shock patients remains controversial. 
The discrepant results of the two recent, landmark trials, the French multicenter study and 
European multicenter trial (CORTICUS) 10, 11, have fueled debates with regard to the 
benefits of low dose corticosteroid use in septic shock patients. The French multi-center 
trial demonstrated that low dose corticosteroid significantly reduced mortality among 
patients with CIRCI and refractory septic shock despite fluid challenge and vasopressor 
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treatment. These results had subsequently been incorporated into the Surviving Sepsis 
Campaign (SSC) Guidelines of 2004, which recommended low dose corticosteroids for 
septic shock patients who require vasopressor therapy to maintain adequate blood 
pressure despite adequate fluid resuscitation 12. However, the CORTICUS study did not 
find improved survival among septic shock patients who received low-dose 
hydrocortisone treatment, despite their adrenal status. The most recent SSC guidelines 
recommended low-dose corticosteroids only for adult patients who responded poorly to 
fluid resuscitation and vasopressor therapy 13. Recent meta-analyses of randomized trials 
reported heterogeneous effects of corticosteroids therapy on mortality 14-17, which 
included patient characteristics, underlying risk, treatment dose and duration.  
 While randomized controlled trials have generated conflicting results, 
appropriately designed observational studies can provide insight into the effects of low 
dose corticosteroids treatment as applied in clinical practice. We conducted a 
retrospective study of prospectively collected data by examining the use of 
corticosteroids treatment as well as its association with mortality in a large cohort of 
septic shock patients admitted to ICUs of our tertiary hospital. The main objective of this 
study was to examine the effectiveness of corticosteroids treatment on hospital mortality 
in all septic shock patients. We also aimed to evaluate the association of this therapy with 
ICU mortality, as well as treatment efficacies within different patient subgroups.  
 
4.2 Methods  
Data Source 
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 This study collected data from the electronic medical records system of an 
academic medical center, which included seven ICUs: three medical, two surgical, one 
cardiac, and one mix unit for trauma, burn, neurosurgical and stroke. Patient information, 
including physiological values, lab tests, diagnoses, care plans and notes, and 
corresponding treatment, was recorded into this system during their entire unit stay by 
health care providers. Microsoft SQL was used to extract patient information from the 
data server. An advantage of this electronic system, compared to paper based medical 
chart extraction, is that, at a lower labor cost, it provides more detailed information about 
each patient.  
 
Study Design and Population 
 This was a retrospective observational cohort study.  All consecutive adult 
patients admitted into seven ICUs between October 2007 and December 2009 were 
analyzed if they were diagnosed with septic shock at anytime during their ICU stay. 
Patients with underlying diseases requiring long-term corticosteroid treatment were 
excluded. 
 This study was part of the “Identifying Patients with Sepsis” project conducted in 
our ICUs and data were collected from existing data without patient identifiers. Our 
Human Subjects Committee approved the study and waived the requirement of informed 
consent.  
 
Data Collection 
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Septic Shock and Shock Onset Time 
 Septic shock in this study was defined as a patient for whom a septic shock 
diagnosis was recorded at any time during an ICU stay. The administration time of the 
first dose vasopressor was defined as the septic shock onset time because clinicians 
usually checked patient status and prescribed appropriate vasopressor based on their best 
judgment before they entered notes and prescription orders into the electronic system at 
the work station in the ICU. For patients with care limitations such as “do not resuscitate 
(DNR)”, “comfort measures only”, and “no vasopressors/inotropes”, their ear liest septic 
shock diagnosis time was considered as the shock onset time. Thus we considered as 
baseline values all the covariates recorded at the time of shock onset or the ones closest to 
shock onset time, since they were more likely to reflect patient status at or right before 
their condition started deteriorating.  
 
Steroid Treatment 
 Steroid treatment was defined as the intravenous administration of hydrocortisone 
in conjunction with a diagnosis of septic shock. The start time of the first dose of 
hydrocortisone was considered as the start time of steroid treatment. We did not collect 
the treatment duration or the total dosage given to patients since some patients were 
discharged from ICU before steroid treatment termination, and the treatment informatio n 
was not available after unit discharge.  
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Patient Outcomes 
 The primary patient outcome was pre-specified as hospital mortality; secondary 
outcomes included ICU mortality. We decided a priori not to measure the association 
between steroid treatment and time to vasopressor therapy withdrawal because some 
patients were discharged from the units before vasopressor withdrawal.  
 
Covariates 
 Patient demographic characteristics, including age, gender, race, marital status, 
height, weight, and admission source were used as covariates. Race was classified as 
white, black and other; marital status was categorized as married, single, or widowed. 
Admission source was classified as emergency department (ED), floor, operating room 
(OR), and other. 
 Physiological parameters included heart rate, respiratory rate, blood pressure, 
temperature, urine output, ventilation status and Glasgow Coma Score. A patient’s 
physiological status was assessed and updated every 30 to 60 minutes during the initial 
24 to 48 hours of ICU stay and is updated every 2 to 4 hours for stable patients. We 
obtained test results and corresponding test time for laboratory tests including WBC 
count, band, platelet, hemoglobin, hematocrit, PT, PTT, INR, glucose, creatinine, 
albumin, anion gap, ALT, AST, blood urea nitrogen, bilirubin, lactate, c-reactive protein 
(CRP), sodium, potassium, cortisol, PaO2, FiO2, PaO2/FiO2 ratio, PaCO2, pH, base 
excess, and microbiology tests (specimen, sites of acquisition, test time, sites with 
positive culture, organism type). Acute Physiology And Chronic Health Evaluation 
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(APACHE) IV score, and one of its components, Acute Physiological Score (APS) were 
calculated using a commercially available program (Cerner, Kansas City, MO).  
 Comorbid diseases were identified by searching patients’ admission diagnoses, 
diagnoses made after the time of ICU admission, and physicians’ daily care notes. 
Fourteen disease categories associated with patient outcome or physician’s decisions 
about steroid treatment were pre-specified by consulting a senior intensivist: 
hypertension, coronary artery disease, congestive heart failure, neurological disease, 
chronic obstructive pulmonary disease, other pulmonary disorder, localized cancer, 
metastatic cancer, diabetes, cirrhosis, other liver disorder, chronic renal failure, AIDS, 
and immunosuppression. In addition, we identified patients who had received 
chemotherapy within the last 6 months, underwent organ transplant, or had received 
corticosteroids within the last 4 months.  
 
DNR status and other care limitation 
 A patient was classified as DNR present if he/she was designated “Comfort 
measures only” or “Do not resuscitate (DNR)” in the electronic record. Other care 
limitation consisted of “No CPR”, “No cardioversion”, “No blood draws”, “No 
intubation”, “No blood products”, and “No vasopressors or inotropes”.  
 
Procedure and Treatment 
We identified patients who received an arterial catheter, central venous catheter, 
mechanical ventilation, etomidate, a fluid bolus, antimicrobial therapy, vasopressor, 
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and/or recombinant human activated protein C (rhAPC) during their ICU stay. The start 
time of each procedure/treatment was categorized as before shock onset, at or within 6 
hours of shock onset, or 6 hours after shock onset.  
 
Propensity Score Match 
 To adjust for such treatment selection bias, we calculated a propensity score for 
each patient to indicate his/her probability of receiving corticosteroid therapy. By 
consulting a senior critical care specialist, we pre-specified a list of variables that could 
affect the decision to use corticosteroid therapy. These included age, gender, race, unit 
admission source, ICU admission diagnosis, DNR status, Glasgow Coma Score, weight, 
temperature, blood pressure, respiratory rate, heart rate, PaO2/FiO2 ratio, PacO2, pH, 
WBC, hematocrit, sodium, potassium, creatinine, bilirubin, albumin, urine output, lactate, 
culture test, cancer, AIDS, cirrhosis, immunosuppression, chemotherapy within the past 
six months, corticotropin stimulation test, central venous catheters, arterial catheters, 
fluid bolus administration, vasopressor prescription, rhAPC, mechanical ventilation, 
etomidate, and antimicrobial therapy. We used the test values that were recorded closest 
to septic shock onset time because clinicians were most likely to refer to them in the 
context of making a treatment decision regarding the use of corticosteroids. Multivariate 
logistic regression with corticosteroid treatment as the outcome was used to determine the 
probability of receiving corticosteroids for each patient. The adequacy of the propensity 
score in adjusting for the effect of included covariates was evaluated by determining 
whether covariates were balanced between patients with or without corticosteroid 
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therapy. Patients without corticosteroids therapy were then matched to patients with 
corticosteroids therapy using nearest neighbor one-to-one match algorithm without 
replacement. We also imposed a caliper of 0.10 on the maximum propensity score 
distance between two patients within the same matched pair to ensure the balance 
between the two groups. Sensitivity analysis was performed to determine if there was 
unmeasured hidden bias that was not accounted for in the propensity regression.  
   
Analyses 
 Summary statistics were calculated using mean and medians for continuous 
variables and frequencies for categorical variables. Differences between groups with and 
without corticosteroid therapy were determined using t test, Wilcoxon rank sum test, chi 
square test or Fisher exact test, as appropriate. Differences in hospital and ICU mortality 
were evaluated using the McNemar test. The association of corticosteroid therapy with 
hospital mortality and ICU mortality were determined using multivariate logistic 
regression after adjustment for propensity score alone, covariates, or propensity score (in 
deciles) and covariates. 
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4.3 Results  
Patient Characteristics  
There were 13,199 patient ICU admissions between October 2007 and December 
2009. Of these patients, 919 had a diagnosis of septic shock during their ICU stay. 
Seventy-six patients with an inaccurate unit admission registration were excluded from 
analysis. We also excluded those with inflammatory bowel disease, Addison’s disease, 
adrenalectomy, myasthenia gravis, or emphysema, to remove the possible confounder 
that these patients might benefit from adrenal replacement therapy independent of any 
indication of septic shock treatment. In addition, their propensity of receiving 
corticosteroids was equal to 1, which made it impossible to find matching patients in the 
untreated group who also had these chronic conditions. 
Of the 841 septic shock patients, 698 (83 %) had septic shock at ICU admission or 
shock onset within the initial 24 hours after unit admission; an additional 143 (17 %) 
were diagnosed with septic shock later during their ICU stay; the average shock onset 
time for this group was 121 hours (SD: 195) after ICU admission. A total of 34% of (290 
out of 841) patients received corticosteroid therapy, and 77% (649 out of 841) received 
vasopressors. Of the patients receiving vasopressors, 38% (245 out of 649) received low-
dose corticosteroids; whereas, 16% (45 out of 290) receiving low-dose corticosteroids 
never received vasopressors. The baseline characteristics of these patients are shown in 
Table 4.1. Patients treated with low-dose corticosteroids were more likely to be female, 
younger (mean age 62.2 versus 65.7 years), and have a higher body mass index (BMI). 
There were fewer treated patients having DNR or other care limitations orders at 
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baseline. All the patients in this study were severely ill, but the APACHE IV scores and 
APS scores were significantly higher in the low-dose corticosteroids group compared to 
the group without low-dose corticosteroid treatment. The physiological values and lab 
tests results were comparable, except for lactate and heart rate which were more 
abnormal in patients treated with low-dose corticosteroids. There was a non-significant 
trend toward the low-dose corticosteroids group receiving more aggressive management 
at baseline such as central venous catheterization, arterial catheterization, etomidate 
administration, and mechanical ventilation. Additionally, patients receiving low dose 
corticosteroids were more likely to receive other treatments (vasopressors and rhAPC) for 
septic shock. 
 Unadjusted outcomes for hospital and ICU mortality and length of stay are 
summarized in Table 4.2. Patients treated with low-dose corticosteroids had significantly 
higher unadjusted hospital and ICU mortality than patients not treated with low-dose 
corticosteroids. Moreover, patients receiving corticosteroids stayed longer both in the 
ICU and in the hospital compared to those not receiving corticosteroids.  
 
Propensity Matched Analysis 
 The area under the receiver operating characteristics curve (ROC) was 0.72 for 
the multivariate logistic regression of low-dose corticosteroids treatment among all 
patients, implying good differentiation between patients treated with and those not treated 
with low-dose corticosteroids. Propensity scores for the two treatment groups largely 
overlapped, and 279 patients receiving low-dose corticosteroids (propensity score mean, 
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0.42; range, 0.05 – 0.85) were successfully matched with 279 patients without low-dose 
corticosteroids treatment (propensity score mean, 0.39; range, 0.05 – 0.86). Patient base 
line characteristics were much more similar and balanced (no significant differences were 
present for any of the covariates) between the exposure group and matched control group, 
as shown in Table 4.3 and Figure 4.1. Similar propensity regression models were carried 
out for the prospectively defined subgroups and the ROCs ranged from 0.72 to 0.83. For 
each subgroup analysis, the same one to one propensity matching strategy was conducted 
before comparing outcomes between the low-dose corticosteroid group and control 
group. The number of successfully matched pairs for each subgroup analysis is presented 
in Appendix Table 4.1.  
 
Relationship of Low-Dose Corticosteroids Therapy with Mortality 
 The unadjusted possibility of dying in the hospital conditional on treatment 
exposure was significantly higher in the low-dose corticosteroid group than the group not 
treated with low-dose corticosteroids (OR, 1.67; 95% CI: 1.26, 2.23; P <0.01). For 
matched pairs, a significantly increased hospital mortality was observed in the exposure 
group (52% vs. 43%; OR, 1.44; 95% CI: 1.01, 2.08; P =0.04) (Table 4.4).  
 Similarly, ICU mortality was consistently higher in the group treated with low-
dose corticosteroids than the control group in both the unadjusted (OR, 1.88; 95% CI: 
1.40, 2.51; P<0.01) and matched group comparisons (OR, 1.57; 95% CI: 1.07, 2.32; P 
=0.01).  
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 Subgroup analyses were conducted by patient severity based on APACHE score, 
among patients with septic shock onset within 24 hours after ICU admission, and among 
patients treated with vasopressors, etomidate, or low-dose corticosteroid treatment 
initiated within 8, 24, or 72 hours or later after shock onset. For hospital mortality, most 
subgroup analyses showed a non-significant trend that patients receiving corticosteroids 
were associated with a higher mortality (Appendix Table 4.1). Among patients with 
higher acuity, whose APACHE score was above the median, regression analyses 
controlling for other covariates showed a significantly higher mortality for patients 
receiving than those not receiving low-dose corticosteroid treatment for septic shock 
(OR, 1.72; 95% CI: 1.05, 2.81; P =0.03). For patients treated with corticosteroids after 8 
hours of shock onset, regression analyses demonstrated that treated patients were 44% 
more likely to die in the hospital than those in the control group. However, the propensity 
score match did not detect significant differences in hospital mortality for all the 
subgroup analyses. The patterns were similar for ICU mortality when comparing the 
treatment to control group patients.  
 Finally, our statistical power analysis indicated that with a sample size of 841 
where 34.5% were treated patients, we had 80% power to detect an absolute difference of 
17 percentage points in hospital mortality between two groups, or a corresponding odds 
ratio of 1.445, based on a 2 sided test and a statistical significance level of 0.05.  
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4.4 Discussion 
 The Surviving Sepsis Campaign (SSC) 2008 guidelines recommend low-dose 
corticosteroids for patients who respond poorly to fluid resuscitation and vasopressor 
treatment in spite of the uncertain treatment effects on patient survival. Moreover, it has 
been reported that low-dose corticosteroids have been widely adopted in clinical practice 
globally 18. This study, to our knowledge, is the largest study in the US that specifically 
evaluated the relationship of low-dose corticosteroids with mortality in ICU patients with 
septic shock in a clinical setting. We found that about one third of our ICU patients with 
septic shock received low-dose corticosteroids, and they had higher hospital mortality 
than those who not treated with corticosteroids.  
 Being aware that this was an observational study and patients were not randomly 
assigned to treatment group, we followed these steps to account for potentially 
confounding variables when we assessed the association of low-dose corticosteroids with 
patient mortality. First, we used propensity score analysis to balance the probability of 
being treated with low-dose corticosteroids. We identified an extensive list of variables 
that related to the decision to prescribe low-dose corticosteroids and calculated 
propensity scores to account for these variables. Two hundred seventy-nine pairs of 
patients were then matched on propensity of the treatment with corticosteroids, and their 
baseline characteristics were evenly distributed between patients treated with and not 
treated with low-dose corticosteroids. Comparing the two groups of patients 
demonstrated significantly higher hospital and ICU mortality for patients in the 
corticosteroid treatment group than the comparison group. Second, the effectiveness of 
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low-dose corticosteroids on patient mortality was evaluated by a series of multivariate 
logistic regression analyses using the entire patient population (n=841) and multiple 
subgroups. Effect estimates from these models consistently pointed to increased risk of 
death for the group of patients treated with low-dose corticosteroids, although these 
estimates modestly differed in their magnitude. In addition, the propensity score method 
generated more conservative effect estimates of treatment, which were found to be closer 
to the null effect (OR=1). Thirdly, subgroup analyses were conducted for important 
patient characteristics including disease severity, vasopressor treatment, early or late 
septic shock onset during the course of ICU stay, low-dose corticosteroid treatment 
initiated within 8, 24, or 72 hours or later after shock onset, and treatment with etomidate. 
Results from these subgroup analyses failed to identify beneficial effects of treatment 
with low dose corticosteroids.  
 We found there was no survival benefit, but increased harm associated with low-
dose corticosteroids treatment. These results are consistent with previous studies which 
found no benefits or even higher mortality with low-dose corticosteroid treatment 11, 16, 18-
20. Our results distinct from the findings of randomized controlled trial by Annane et al. 
and those of two recent meta-analyses of randomized controlled trials 10, 14, 15. A possible 
explanation for these divergent findings is that the effects of corticosteroids depend on 
the patient’s underlying risk: a true positive effect, if it exists, could be obscured by 
lumping heterogeneous groups of patients together. However, we conducted a series of 
subgroup analyses and failed to identify any subgroup that benefited from the low-dose 
corticosteroid treatment. Moreover, the patient population in our study differed from 
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those in randomized controlled trials. Indeed, 15% of the patients in our study were not 
treated with a vasoconstrictor and would have been excluded from trails of septic shock. 
In addition, increased mortality for patients treated with low dose corticosteroids without 
or before fluid bolus and vasopressors treatment might partially explain why harm was 
detected in clinical practice that was not noted in the clinical trials. Another possible 
explanation for the findings of our study is that low-dose corticosteroids therapy may 
serve as an indicator that patients treated with low-dose corticosteroids are also the ones 
receiving more aggressive, invasive care in our ICUs. It is possible that these more 
aggressive treatments may cause harm themselves or offset any benefits from 
corticosteroid therapy. A fourth explanation is that we still do not thoroughly understand 
the mechanisms for low-dose corticosteroids therapy. Although increased cortisol is 
believed to exert protective physiologic effects through modulating metabolism, 
maintaining microvascular perfusion, increasing sensitivity of vascular muscle to 
endogenous or exogenous vasopressors agents, and modulating the immune system 
function 21-23 , it has also been reported that treatment with low-dose corticosteroids 
induces hyperglycemia, which in itself is a risk factor for mortality in the ICU. 
Additionally, the study by Ho, et al. found that plasma nitric oxide (NO) levels were not 
decreased by hydrocortisone administration 24. 
 The strength of this study is that it included a substantial number of patients in a 
clinical practice setting. In addition, we were able to accurately measure patients’ 
baseline characteristics; especially for those who had septic shock onset later during their 
ICU stay. Their “baseline” characteristics at ICU admission may not reflect actual 
109 
 
 
baseline characteristics at shock onset. A rigorous analytical strategy was applied to this 
study including using propensity score to adjust for treatment selection bias. Our study 
was limited by its observational design, for which we could not exclude the possibility 
that our findings were confounded by unmeasured factors. Another limitation was that we 
only included patients from a single healthcare system, which may not be representative 
of healthcare systems in other geographic areas. Finally, there was a consistent trend in 
all the subgroup analyses that associated low dose corticosteroid treatment with a higher 
mortality; as suggested by our power analysis, however, we might have lacked adequate 
power to detect the differences in mortality between the corticosteroid treatment group 
and the comparison group due to smaller sample sizes used in the subgroup analyses.  
 
4.5 Conclusions 
 In conclusion, this study did not identify survival benefits in septic shock patients 
receiving low-dose corticosteroids. The results hold for all of the investigated subgroups 
across levels of disease severity, early or late onset during ICU stay, the timing of 
corticosteroids administration, and treatment with vasopressors or etomidate. These 
findings suggest that caution should be used when considering a recommendation for the 
use of low dose corticosteroids in clinical practice guidelines for the management of 
sepsis. 
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Table 4.1   Patient Characteristics before Propensity Score Match 
Characteristics 
Treated Patients 
(n=290) 
Control Patients 
(n=551) 
Bias 
(% ) 
P 
Value 
Age, mean ± SD 62.20±15.89 65.74±16.37 -21.95 <0.01 
Female Gender, n (%) 147 (50.69) 235 (42.65) 16.17 0.03 
Race, n (%)     
    White  260 (89.66) 479 (86.93) 8.48 0.25 
    Black 7 (2.41) 22 (3.99) -8.98 0.23 
    Other 23 (7.93) 50 (9.07) -4.1 0.58 
Married Status, n (%) 122 (42.07) 251 (45.55) -7.03 0.33 
BMI, mean ± SD 29.09±8.46 28.29±7.71 9.95 0.16 
APS Score, mean ± SD 84.25±30.93 75.30±27.05 30.81 <0.01 
APACHE Score, mean ± SD 97.56±31.36 89.09±28.64 28.23 <0.01 
DNR status, n (%) 15 (5.17) 48 (8.71) -13.96 0.06 
Admission Source, n (%)      
    Emergency Room 161 (55.52) 326 (59.17) -7.38 0.31 
    Ward  55 (18.97) 111 (20.15) -2.97 0.68 
    Operation Room 28 (9.66) 41 (7.44) 7.93 0.27 
    Other Hospital 46 (15.86) 73 (13.25) 7.42 0.30 
Operative Diagnosis, n (%) 25 (8.62) 33 (5.99) 10.13 0.15 
Admission Diagnosis, n (%)      
    Cardiovascular  129 (44.48) 247 (44.83) -0.69 0.92 
    Gastrointestinal 43 (14.83) 71 (12.89) 5.62 0.43 
    Respiratory  66 (22.76) 108 (19.60) 7.73 0.28 
    Genitourinary  8 (2.76) 31 (5.63) -14.34 0.06 
    Neurology 7 (2.41) 23 (4.17) -9.88 0.19 
    Other 37 (12.76) 71 (12.89) -0.38 0.96 
Comorbid ities, n (%)      
    Hypertension 137 (47.24) 285 (51.72) -8.98 0.22 
    Coronary Artery Disease 53 (18.28) 125 (22.69) -10.94 0.14 
    Chronic Heart Failure  40 (13.79) 96 (17.42) -10.01 0.17 
    Neurological Disease 161 (55.52) 291 (52.81) 5.43 0.45 
    Chronic Pulmonary Disease 91 (31.38) 165 (29.95) 3.11 0.67 
    Cancer 71 (24.48) 102 (18.51) 14.57 0.04 
    Diabetes 80 (27.59) 177 (32.12) -9.93 0.17 
    Liver Disease 44 (15.17) 88 (15.97) -2.2 0.76 
    Chronic Renal Failure  21 (7.24) 56 (10.16) -10.38 0.16 
GCS score, mean ± SD 11.69±4.10 11.86±4.12 -4.11 0.57 
Temperature, mean ± SD 37.12±1.26 37.13±1.06 -0.66 0.93 
Temperature less than 36 °C, n (%) 33 (11.38) 49 (8.89) 8.25 0.25 
Heart Rate, mean ± SD 99.07±23.42 95.43±20.56 16.48 0.02 
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Respiratory Rate, mean ± SD 21.98±6.94 21.29±6.00 10.68 0.13 
Diastolic Blood Pressure, mean ± SD 53.97±14.55 51.55±15.79 15.94 0.03 
Systolic Blood Pressure, mean ± SD 101.64±24.19 100.95±22.03 2.97 0.68 
Urine Output (ml) in 24 Hours , mean 
± SD 
1,625.09±1,755.75 2,041.94±4,486.25 -12.24 0.13 
WBC Count, mean ± SD 14.52±11.70 15.20±13.06 -5.47 0.46 
Band, mean ± SD 17.24±15.93 16.67±15.07 3.66 0.61 
Creat inine, mean ± SD 2.07±1.61 2.23±2.06 -8.47 0.26 
Glucose, mean ± SD 134.46±73.70 145.70±118.03 -11.42 0.14 
HCT, mean ± SD 30.87±6.36 31.24±6.40 -5.88 0.42 
Lactate, mean ± SD 3.77±3.97 2.69±2.70 31.73 <0.01 
paCO2, mean ± SD 41.52±13.06 41.50±12.66 0.21 0.98 
FiO2, mean ± SD 66.39±25.50 61.67±25.65 18.48 0.01 
PH, mean ± SD 7.29±0.13 7.31±0.12 -18.6 0.01 
Potassium, mean ± SD 4.26±0.84 4.29±0.86 -3.67 0.61 
Sodium, mean ± SD 138.10±5.30 138.67±5.74 -10.34 0.16 
Total Bilirubin, mean ± SD 2.33±4.43 2.09±4.40 5.52 0.45 
Platelet, mean ± SD 176.74±107.00 200.03±117.73 -20.7 0.01 
BUN, mean ± SD 34.68±24.03 39.44±31.16 -17.13 0.02 
AnionGap, mean ± SD 9.67±5.36 9.21±4.38 9.22 0.19 
Albumin, mean ± SD 2.76±0.89 2.81±0.86 -5.01 0.49 
Cortisol, mean ± SD 21.16±17.81 22.76±18.77 -8.72 0.23 
CRP, mean ± SD 9.61±18.20 10.78±21.24 -5.93 0.42 
Direct Bilirubin, mean ± SD 0.58±1.70 0.52±1.64 3.8 0.60 
ALT, mean ± SD 106.13±340.18 108.95±473.09 -0.68 0.93 
AST, mean ± SD 217.59±1,021.47 188.45±842.77 3.11 0.66 
Treatment at or before shock onset, n (%)  
Central venous catheter 182 (62.76) 317 (57.53) 10.69 0.14 
Arterial catheter 66 (22.76) 107 (19.42) 8.19 0.25 
Mechanical ventilation  113 (38.97) 183 (33.21) 12 0.10 
Vasopressor 245 (84.48) 404 (73.32) 27.62 <0.01 
Etomidate 84 (28.97) 124 (22.50) 14.82 0.04 
Antimicrobial 279 (96.21) 520 (94.37) 8.66 0.25 
rhAPC 16 (5.52) 3 (0.54) 29.32 <0.01 
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Table 4.2   Unadjusted outcomes 
Outcome Treated Patients 
(n=290) 
Control Patients 
(n=551) 
P Value 
Hospital Mortality, n (%) 150 (51.72%) 215 (39.02%) <0.01 
ICU mortality, n (%) 134 (46.21%) 173 (31.40%) <0.01 
Hospital Length of Stay, mean ± 
SD 18.11±18.54 14.58±15.00 <0.01 
ICU Length of Stay, mean ± SD 12.04±14.33 8.04±9.69 <0.01 
 
113 
 
 
Table 4.3   Patient Characteristics after Propensity Score Match 
Characteristics Treated Patients 
(n=279) 
Control Patients 
(n=279) 
Bias 
(% ) 
P 
Value 
Age, mean ± SD 62.43±15.84 63.14±16.54 -4.42 0.60 
Female Gender, n (%) 140 (50.18) 141 (50.54) -0.72 0.93 
Race, n (%)      
    White  250 (89.61) 247 (88.53) 3.45 0.68 
    Black 7 (2.51) 7 (2.51) 0 1.00 
    Other 22 (7.89) 25 (8.96) -3.87 0.65 
Married Status, n (%) 118 (42.29) 115 (41.22) 2.18 0.80 
BMI, mean ± SD 28.93±8.26 28.92±8.51 0.06 0.99 
APS Score, mean ± SD 83.22±30.46 80.91±28.20 7.85 0.35 
APACHE Score, mean ± SD 96.67±31.08 94.27±29.67 7.9 0.35 
DNR status, n (%) 15 (5.38) 16 (5.73) -1.56 0.85 
Admission Source, n (%)      
    Emergency Room 157 (56.27) 149 (53.41) 5.76 0.50 
    Ward  53 (19.00) 59 (21.15) -5.37 0.53 
    Operation Room 26 (9.32) 23 (8.24) 3.8 0.65 
    Other Hospital 43 (15.41) 48 (17.20) -4.85 0.57 
Operative Diagnosis, n (%) 23 (8.24) 15 (5.38) 11.4 0.18 
Admission Diagnosis, n (%)      
    Cardiovascular  126 (45.16) 121 (43.37) 3.61 0.67 
    Gastrointestinal 42 (15.05) 41 (14.70) 1.01 0.91 
    Respiratory  59 (21.15) 58 (20.79) 0.88 0.92 
    Genitourinary  8 (2.87) 11 (3.94) -5.93 0.48 
    Neurology 7 (2.51) 8 (2.87) -2.22 0.79 
    Other 37 (13.26) 40 (14.34) -3.12 0.71 
Comorbid ities, n (%)      
    Hypertension 132 (47.31) 132 (47.31) 0 1.00 
    Coronary Artery Disease 51 (18.28) 54 (19.35) -2.75 0.75 
    Chronic Heart Failure  40 (14.34) 39 (13.98) 1.03 0.90 
    Neurological Disease 155 (55.56) 162 (58.06) -5.07 0.55 
    Chronic Pulmonary Disease 87 (31.18) 86 (30.82) 0.77 0.93 
    Cancer 69 (24.73) 61 (21.86) 6.79 0.42 
    Diabetes 77 (27.60) 79 (28.32) -1.6 0.85 
    Liver Disease 43 (15.41) 43 (15.41) 0 1.00 
    Chronic Renal Failure  21 (7.53) 26 (9.32) -6.46 0.45 
GCS score, mean ± SD 11.75±4.08 11.40±4.49 8.1 0.34 
Temperature, mean ± SD 37.10±1.25 37.14±1.12 -3.89 0.65 
Temperature less than 36 °C, n (%) 32 (11.47) 32 (11.47) 0 1.00 
Heart Rate, mean ± SD 98.35±22.90 98.45±20.15 -0.48 0.95 
Respiratory Rate, mean ± SD 21.86±6.97 21.56±6.28 4.54 0.59 
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Diastolic Blood Pressure, mean ± SD 53.49±14.33 53.74±18.02 -1.52 0.86 
Systolic Blood Pressure, mean ± SD 100.99±23.96 101.04±23.58 -0.2 0.98 
Urine Output (ml) in 24 Hours , mean ± SD 1,667.23±1,773.44 1,686.91±1,979.75 -1.05 0.90 
WBC Count, mean ± SD 14.74±11.78 14.74±9.86 -0.06 0.99 
Band, mean ± SD 17.18±15.86 17.67±15.79 -3.11 0.71 
Creat inine, mean ± SD 2.07±1.62 2.08±1.75 -0.6 0.94 
Glucose, mean ± SD 134.97±74.88 132.41±63.64 3.68 0.66 
HCT, mean ± SD 30.85±6.37 31.04±6.41 -2.91 0.73 
Lactate, mean ± SD 3.69±3.86 3.19±3.20 14.18 0.09 
paCO2, mean ± SD 41.35±12.99 41.90±13.08 -4.21 0.62 
FiO2, mean ± SD 65.37±25.32 63.68±25.18 6.7 0.43 
PH, mean ± SD 7.29±0.13 7.30±0.14 -4.66 0.58 
Potassium, mean ± SD 4.26±0.85 4.28±0.88 -1.83 0.83 
Sodium, mean ± SD 138.06±5.37 138.32±5.56 -4.66 0.58 
Total Bilirubin, mean ± SD 2.36±4.50 2.70±5.99 -6.38 0.45 
Platelet, mean ± SD 177.57±106.80 186.23±110.48 -7.97 0.35 
BUN, mean ± SD 34.75±24.14 35.15±24.66 -1.63 0.85 
AnionGap, mean ± SD 9.63±5.39 9.38±4.44 5.01 0.55 
Albumin, mean ± SD 2.75±0.90 2.76±0.87 -1.58 0.85 
Cortisol, mean ± SD 21.30±18.11 22.79±18.71 -8.12 0.34 
CRP, mean ± SD 9.68±18.55 9.27±14.69 2.46 0.77 
Direct Bilirubin, mean ± SD 0.59±1.73 0.73±2.20 -7.41 0.38 
ALT, mean ± SD 108.91±346.46 152.25±629.71 -8.53 0.31 
AST, mean ± SD 221.01±1,040.83 263.31±1,046.69 -4.05 0.63 
Treatment at or before shock onset, n (%)      
Central venous catheter 174 (62.37) 178 (63.80) -2.97 0.73 
Arterial catheter 61 (21.86) 59 (21.15) 1.74 0.84 
Mechanical ventilation  108 (38.71) 100 (35.84) 5.93 0.48 
Vasopressor 235 (84.23) 234 (83.87) 0.98 0.91 
Etomidate 77 (27.60) 72 (25.81) 4.05 0.63 
Antimicrobial 268 (96.06) 263 (94.27) 8.36 0.32 
rhAPC 7 (2.51) 2 (0.72) 14.26 0.09 
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Table 4.4   Hospital Mortality by Hydrocortisone Use 
Hos pital  Mortality N Odds 
Ratio 
95%  CI P-
value Low High 
Unadjusted Difference 841 1.67 1.26 2.23 <0.01 
Propensity Score Matched 558 1.44 1.01 2.08 0.04 
Adjusted Difference Controlling for Other Covariates 841 1.58 1.10 2.26 0.01 
Adjusted Difference Controlling for Other Covariates 
       and the Deciles of Propensity Score 841 1.51 1.04 2.20 0.03 
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Table 4.5   ICU Mortality by Hydrocortisone Use 
ICU Mortality N Odds 
Ratio 
95%  CI 
P-value 
Low High 
Unadjusted Difference 841 1.88 1.40 2.51 <0.01 
Propensity Score Matched 558 1.57 1.08 2.32 0.01 
Adjusted Difference Controlling for Other Covariates 841 1.65 1.14 2.38 0.01 
Adjusted Difference Controlling for Other Covariates 
       and the Docile o f Propensity Score 841 1.56 1.06 2.28 0.02 
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Appendix Table 4.1   Hospital Mortality by Hydrocortisone Use – Subgroup Analysis 
Hos pital  Mortality N Odds 
Ratio 
95%  CI P-
value Low High 
Subgroup Analysis - 50% more severe patients 
Unadjusted Difference 468 1.51 1.03 2.20 0.04 
Propensity Score Matched 310 1.32 0.81 2.18 0.24 
Adjusted Difference Controlling for Other 
Covariates 468 1.72 1.05 2.81 0.03 
Adjusted Difference Controlling for Other 
Covariates and the Deciles of Propensity Score 
468 1.40 0.82 2.41 0.22 
Subgroup Analysis - 50% less severe patients 
Unadjusted Difference 361 1.71 1.05 2.79 0.03 
Propensity Score Matched 196 1.11 0.57 2.17 0.75 
Adjusted Difference Controlling for Other 
Covariates 
361 1.38 0.77 2.49 0.28 
Adjusted Difference Controlling for Other 
Covariates and the Deciles of Propensity Score 361 1.04 0.54 2.02 0.91 
Subgroup Analysis - septic shock onset within 24hr after ICU admission 
Unadjusted Difference 698 1.63 1.19 2.24 <0.01 
Propensity Score Matched 448 1.33 0.89 2.01 0.14 
Adjusted Difference Controlling for Other 
Covariates 698 1.43 0.96 2.13 0.08 
Adjusted Difference Controlling for Other 
Covariates and the Deciles of Propensity Score 
698 1.42 0.93 2.17 0.11 
Subgroup Analysis - treated with vasopressor 
Unadjusted Difference 650 1.64 1.22 2.20 <0.01 
Propensity Score Matched 464 1.22 0.83 1.82 0.29 
Adjusted Difference Controlling for Other 
Covariates 
650 1.43 0.97 2.12 0.07 
Adjusted Difference Controlling for Other 
Covariates and the Deciles of Propensity Score 
650 1.42 0.94 2.13 0.09 
Subgroup Analysis - treated with etomidate 
Unadjusted Difference 208 1.29 0.74 2.25 0.37 
Propensity Score Matched 110 1.14 0.52 2.53 0.72 
Adjusted Difference Controlling for Other 
Covariates 
207 1.53 0.69 3.38 0.29 
Adjusted Difference Controlling for Other 
Covariates and the Deciles of Propensity Score 207 1.39 0.55 3.56 0.49 
Subgroup Analysis - corticosteroids use within 8 hours after shock onset 
Unadjusted Difference 713 1.52 1.07 2.16 0.19 
Propensity Score Matched 300 1.24 0.74 2.09 0.39 
Adjusted Difference Controlling for Other 
Covariates 713 1.17 0.74 1.85 0.51 
Adjusted Difference Controlling for Other 
Covariates and the Deciles of Propensity Score 
713 1.07 0.65 1.75 0.80 
Subgroup Analysis - corticosteroids use after 8 hours after shock onset 
Unadjusted Difference 679 1.89 1.28 2.78 <0.01 
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Propensity Score Matched 250 1.44 0.86 2.45 0.14 
Adjusted Difference Controlling for Other 
Covariates 
679 2.30 1.42 3.71 <0.01 
Adjusted Difference Controlling for Other 
Covariates and the Deciles of Propensity Score 679 2.21 1.36 3.59 <0.01 
Subgroup Analysis - corticosteroids use within 24 hours after shock onset 
Unadjusted Difference 721 1.93 1.37 2.74 <0.01 
Propensity Score Matched 306 1.16 0.70 1.92 0.55 
Adjusted Difference Controlling for Other 
Covariates 
721 1.41 0.89 2.23 0.14 
Adjusted Difference Controlling for Other 
Covariates  and the Deciles of Propensity Score 721 1.34 0.83 2.17 0.24 
Subgroup Analysis - corticosteroids use after 24 hours after shock onset 
Unadjusted Difference 671 1.37 0.92 2.03 0.12 
Propensity Score Matched 234 1.63 0.89 3.06 0.09 
Adjusted Difference Controlling for Other 
Covariates 671 1.76 1.09 2.83 0.02 
Adjusted Difference Controlling for Other 
Covariates  and the Deciles of Propensity Score 671 1.74 1.06 2.86 0.03 
Subgroup Analysis  - corticosteroids use within 72 hours after shock onset 
Unadjusted Difference 798 1.65 1.22 2.24 <0.01 
Propensity Score Matched 466 1.02 0.69 1.50 0.93 
Adjusted Difference Controlling for Other 
Covariates 
798 1.33 0.90 1.97 0.15 
Adjusted Difference Controlling for Other 
Covariates  and the Deciles of Propensity Score 
798 1.31 0.87 1.95 0.20 
Subgroup Analysis - corticosteroids use after 72 hours after shock onset 
Unadjusted Difference 594 1.80 0.96 3.35 0.07 
Propensity Score Matched 84 2.33 0.84 7.41 0.07 
Adjusted Difference Controlling for Other 
Covariates 
594 2.98 1.43 6.20 <0.01 
Adjusted Difference Controlling for Other 
Covariates  and the Deciles of Propensity Score 
594 2.56 1.19 5.48 0.02 
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Appendix Table 4.2   ICU Mortality by Hydrocortisone Use – Subgroup Analysis 
ICU Mortality N Odds 
Ratio 
95%  CI 
P-value 
Low High 
Subgroup Analysis - 50% more severe patients 
Unadjusted Difference 468 1.63 1.12 2.38 0.01 
Propensity Score Matched 310 1.28 0.79 2.10 0.29 
Adjusted Difference Controlling for Other Covariates 468 1.56 0.96 2.55 0.08 
Adjusted Difference Controlling for Other Covariates 
       and the Deciles of Propensity Score 468 1.51 0.88 2.58 0.13 
Subgroup Analysis - 50% less severe patients 
Unadjusted Difference 361 2.03 1.21 3.40 0.01 
Propensity Score Matched 196 1.29 0.66 2.60 0.42 
Adjusted Difference Controlling for Other Covariates 355 1.49 0.78 2.85 0.23 
Adjusted Difference Controlling for Other Covariates 
       and the Deciles of Propensity Score 
355 1.26 0.60 2.65 0.54 
Subgroup Analysis - septic shock onset within 24hr after ICU admission 
Unadjusted Difference 698 1.75 1.26 2.42 <0.01 
Propensity Score Matched 448 1.24 0.83 1.89 0.27 
Adjusted Difference Controlling for Other Covariates 698 1.31 0.86 1.99 0.20 
Adjusted Difference Controlling for Other Covariates 
       and the Deciles of Propensity Score 
698 1.27 0.82 1.98 0.29 
Subgroup Analysis - treated with vasopressor 
Unadjusted Difference 650 1.81 1.31 2.49 <0.01 
Propensity Score Matched 464 1.33 0.90 1.98 0.13 
Adjusted Difference Controlling for Other Covariates 650 1.54 1.03 2.30 0.04 
Adjusted Difference Controlling for Other Covariates 
       and the Deciles of Propensity Score 
650 1.55 1.02 2.36 0.04 
Subgroup Analysis - treated with etomidate 
Unadjusted Difference 208 1.48 0.85 2.59 0.17 
Propensity Score Matched 110 1.13 0.53 2.44 0.72 
Adjusted Difference Controlling for Other Covariates 207 1.53 0.71 3.33 0.28 
Adjusted Difference Controlling for Other Covariates 
       and the Deciles of Propensity Score 
207 1.75 0.71 4.33 0.23 
Subgroup Analysis - corticosteroids use within 8 hours after shock onset 
Unadjusted Difference 713 1.75 1.22 2.50 0.02 
Propensity Score Matched 300 1.30 0.79 2.17 0.28 
Adjusted Difference Controlling for Other Covariates 713 1.23 0.77 1.95 0.39 
Adjusted Difference Controlling for Other Covariates 
       and the Deciles of Propensity Score 
713 1.07 0.64 1.78 0.79 
Subgroup Analysis - corticosteroids use after 8 hours after shock onset 
Unadjusted Difference 679 2.05 1.39 3.03 <0.01 
Propensity Score Matched 250 1.52 0.87 2.70 0.11 
Adjusted Difference Controlling for Other Covariates 679 2.41 1.48 3.94 <0.01 
Adjusted Difference Controlling for Other Covariates 
       and the Deciles of Propensity Score 679 2.47 1.49 4.08 <0.01 
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Subgroup Analysis - corticosteroids use within 24 hours after shock onset 
Unadjusted Difference 721 2.29 1.61 3.25 <0.01 
Propensity Score Matched 306 1.13 0.68 1.87 0.63 
Adjusted Difference Controlling for Other 
Covariates 721 1.55 0.97 2.47 0.07 
Adjusted Difference Controlling for Other 
Covariates  and the Deciles of Propensity Score 
721 1.45 0.89 2.37 0.14 
Subgroup Analysis - corticosteroids use after 24 hours after shock onset 
Unadjusted Difference 671 1.41 0.94 2.12 0.10 
Propensity Score Matched 234 1.72 0.93 3.27 0.06 
Adjusted Difference Controlling for Other 
Covariates 
671 1.81 1.11 2.96 0.02 
Adjusted Difference Controlling for Other 
Covariates  and the Deciles of Propensity Score 671 1.83 1.09 3.07 0.02 
Subgroup Analysis - corticosteroids use within 72 hours after shock onset 
Unadjusted Difference 798 1.90 1.40 2.59 <0.01 
Propensity Score Matched 466 1.16 0.78 1.73 0.44 
Adjusted Difference Controlling for Other 
Covariates 
798 1.46 0.98 2.17 0.06 
Adjusted Difference Controlling for Other 
Covariates  and the Deciles of Propensity Score 
798 1.38 0.91 2.08 0.13 
Subgroup Analysis - corticosteroids use after 72 hours after shock onset 
Unadjusted Difference 594 1.73 0.92 3.24 0.09 
Propensity Score Matched 84 2.40 0.79 8.70 0.09 
Adjusted Difference Controlling for Other 
Covariates 594 3.11 1.44 6.73 <0.01 
Adjusted Difference Controlling for Other 
Covariates  and the Deciles of Propensity Score 
594 2.51 1.13 5.54 0.02 
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Figure 4.1   Patient Characteristics before and after propensity match 
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Chapter V  General Discussions and Final Conclusions 
 
 Despite the rapid progress in the knowledge of pathophysiological mechanisms of 
sepsis and its treatment in the last two decades, sepsis remains as the one of the most 
challenging diseases to critical care clinicians. This dissertation seeks to improve our 
understanding of the diagnostic accuracies of sepsis definitions, promote early 
recognition of sepsis, and advance our knowledge of the treatment effects of low-dose 
steroids. Using the data from the seven ICUs in an academic tertiary care medical center, 
I systematically evaluated the test characteristics of the 1991 and 2001 sepsis definitions; 
explored the algorithms for continuously monitored physiological parameters to 
maximize their diagnostic performance in identifying sepsis patients; and examined the 
effectiveness of corticosteroids treatment on mortality in septic shock patients.  
 
Test characteristics of the 1991 and 2001 consensus sepsis definitions in adult 
critically ill patients using adjudicated sepsis cases as the reference standard 
 Although the 1991 and 2001 consensus definitions 1, 2 of sepsis have been widely 
adopted in clinical practice since their publication, their test characteristics, as well as the 
changes given by the expanded 2001 consensus definition, have not been well studied. 
The research objective of this study was to assess their test characte ristics (i.e. sensitivity, 
specificity, and the area under the ROC curve) of the 1991 and 2001 consensus 
definition, respectively, compared to sepsis case adjudication by three senior intensive 
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care clinicians. I demonstrated that, compared to adjudicated sepsis, both the 1991 and 
2001 definitions had relatively high sensitivity, low specificity, and suboptimal area 
under the ROC curve. Indeed, the criteria in the two definitions include signs and 
symptoms that a patient could present during the course of infection-induced systemic 
inflammatory response. However, they are not specific to sepsis, and many other 
conditions could also have these signs and symptoms.  
  Adding more criteria to the definition list, the 2001 sepsis definition has a 
detailed list of possible manifestations in sepsis. Compared to the 1991 definition, the 
2001 sepsis definition had a slightly increased sensitivity, decreased specificity and 
decreased area under the ROC curve. In addition, when taking into account sepsis 
diagnosis time, the differences between adjudicated sepsis and the two definitions 
became larger. This pointed to the dilemma in clinical practice that, on one hand, the 
signs and symptoms of sepsis patients are dynamic; whereas on the other hand, neither of 
the two definitions provided a time reference within which the defined criteria should be 
met in order to diagnose a patient as having sepsis. From our regression analyses, I also 
identified the predictors of sepsis that could improve the specificity of sepsis diagnosis. 
 
Using continuously monitored physiological parameters to predict the onset of 
Sepsis in Critically Ill Patients 
 Early recognition and treatment for sepsis have been shown to significantly 
reduce sepsis-related mortality.3, 4 However, accurately diagnosing of sepsis, especially 
before patients deteriorate and develop organ dysfunction, is an important goal but often 
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difficult to achieve in practice.5 Previous studies have reported that physiological 
parameters, like heart rate, respiratory rate, body temperature, and blood pressure, had 
inferior diagnostic performance in identifying sepsis patients from the SIRS or non-SIRS 
patients.6, 7 However, no studies have assessed the clinical usefulness of continuously 
monitored physiological parameters for adult patient with sepsis. The goal of this study 
was to determine, first, the changes of the continuously monitored physiological 
parameters, before the onset of sepsis and their relationships with sepsis onset; and 
second, to determine whether these parameters could be used to identify sepsis in 
critically ill adults. I demonstrated that, as early as 24 hours before sepsis diagnosis, 
septic patients tended to be more physiologically disarranged by having higher heart 
rates, lower blood pressure, higher temperatures and higher respiratory rates, compared to 
SIRS or non-SIRS patients. More importantly, continuously monitored physiological 
parameters measured 24 hours before disease onset have improved performance in 
identifying sepsis from SIRS patients and excellent predictive accuracy in distinguishing 
sepsis from non-SIRS critically ill adult patients. The combination of these physiological 
parameters (the minimum blood pressure parameters and the maximum values of heart 
rate, respiratory rate and body temperature) achieved area under ROC curve of 0.74 and 
0.90 in differentiating sepsis from SIRS and non-SIRS, respectively, which were 
comparable to that of procalcitonin published in the literature so far.8, 9 
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The Effectiveness of Corticosteroid Treatment on Septic Shock Patient Outcomes in 
Intensive Care Units  
 Since the introduction of corticosteroids as an adjunctive therapy in severe sepsis 
and septic shock a half century ago, its therapeutic role, in terms of efficacy and safety, 
has been debated. Landmark randomized controlled trials have generated conflicting 
results with regard to the mortality benefit of low-dose corticosteroid treatment.10, 11 
Recent meta-analyses of randomized trials reported heterogeneous effects of 
corticosteroids therapy on mortality,12-14 which was influenced by patient characteristics, 
underlying mortality risk, treatment dose and duration. The purpose of this study was to 
examine the effectiveness of corticosteroids treatment on mortality in all septic shock 
patients admitted to the ICUs of an academic medical center. Since this is an 
observational study, the corticosteroids treatment decision was confounded by the patient 
factors which were also related to their outcomes. To adjust for such treatment selection 
bias, I calculated a propensity score for each patient to indicate his/her probability of 
receiving corticosteroid therapy. I found that about one third of our ICU patients with 
septic shock received low-dose corticosteroids, and they had higher hospital mortality 
than the ones who received no corticosteroids treatment. I also conducted a series of 
subgroup analyses and failed to identify any subgroup that benefit from the low-dose 
corticosteroid treatment across levels of disease severity, early or late onset during ICU 
stay, corticosteroids administration time, or treatment with vasopressors or etomidate. 
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Final Conclusions 
 The three studies in this dissertation contribute to the existing literature regarding 
the test characteristics of sepsis definitions, sepsis prediction, and corticosteroids 
treatment effects among septic shock patients. The findings that both the 1991 and 2001 
sepsis definitions have suboptimal diagnostic accuracy emphasize the needs for more 
specific criteria. Continuously monitored physiological parameters serve as good 
candidates to predict sepsis acute onset among critically ill patients. The promising 
results of the predicting algorithms could be used, as early as 24 hours before sepsis 
onset, to identify sepsis. Moreover, the findings that no survival benefit, or even a slightly 
increased harm, was associated with low-dose corticosteroids treatment in our medical 
center calls for great caution regarding the usage of corticosteroids treatment among 
septic shock patients. Last but not least, these studies utilized innovative analytic 
approaches, for example, the data validation rules and the time windows, and offered new 
ideas for future exploration of data collected by electronic medical record systems.  
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